TIMKEN CO
10-Qs and 10-Ks
PROXIES
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
10-Q
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
For the quarterly period ended
September 30, 2021
OR
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
For the transition period from
to
Commission file number:
1-1169
THE
TIMKEN CO
MPANY
(Exact name of registrant as specified in its charter)
|
|
|
||||||||||
|
(State or other jurisdiction of
incorporation or organization) |
(I.R.S. Employer
Identification No.) |
||||||||||
|
|
|||||||||||
|
|
|
|
|||||||||
| (Address of principal executive offices) | (Zip Code) | ||||||||||
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol | Name of each exchange on which registered | ||||||||||||||||||
|
|
|
|
||||||||||||||||||
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes
☒
No
☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes
☒
No
☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
|
|
☒ | Accelerated filer |
☐
|
||||||||||||||
| Non-accelerated filer |
☐
|
Smaller reporting company |
|
||||||||||||||
| Emerging growth company |
|
||||||||||||||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes
☐
No
☒
Indicate the number of shares outstanding of each of the issuer's classes of common shares, as of the latest practicable date.
| Class |
Outstanding at September 30, 2021
|
|||||||||||||
| Common Shares, without par value |
|
|||||||||||||
THE TIMKEN COMPANY
INDEX TO FORM 10-Q REPORT
| PAGE | |||||||||||
| I. | |||||||||||
| Item 1. | |||||||||||
| Item 2. | |||||||||||
| Item 3. | |||||||||||
| Item 4. | |||||||||||
| II. | |||||||||||
| Item 1. | |||||||||||
| Item1A. | |||||||||||
| Item 2. | |||||||||||
| Item 6. | |||||||||||
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
THE TIMKEN COMPANY AND SUBSIDIARIES
Consolidated Statements of Income
(Unaudited)
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
||||||||||||||||||||||
| 2021 | 2020 | 2021 | 2020 | ||||||||||||||||||||
| (Dollars in millions, except per share data) | |||||||||||||||||||||||
| Net sales | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Cost of products sold |
|
|
|
|
|||||||||||||||||||
| Gross Profit |
|
|
|
|
|||||||||||||||||||
| Selling, general and administrative expenses |
|
|
|
|
|||||||||||||||||||
| Impairment and restructuring charges |
|
|
|
|
|||||||||||||||||||
| Operating Income |
|
|
|
|
|||||||||||||||||||
| Interest expense |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Interest income |
|
|
|
|
|||||||||||||||||||
| Non-service pension and other postretirement income |
|
|
|
|
|||||||||||||||||||
| Other income (expense), net |
|
(
|
|
|
|||||||||||||||||||
| Income Before Income Taxes |
|
|
|
|
|||||||||||||||||||
| Provision for income taxes |
|
|
|
|
|||||||||||||||||||
| Net Income |
|
|
|
|
|||||||||||||||||||
| Less: Net income attributable to noncontrolling interest |
|
|
|
|
|||||||||||||||||||
| Net Income Attributable to The Timken Company | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
Net Income per Common Share Attributable to The Timken Company
Common Shareholders |
|||||||||||||||||||||||
| Basic earnings per share | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Diluted earnings per share | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
See accompanying Notes to the Consolidated Financial Statements.
Consolidated Statements of Comprehensive Income
(Unaudited)
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
||||||||||||||||||||||
| 2021 | 2020 | 2021 | 2020 | ||||||||||||||||||||
| (Dollars in millions) | |||||||||||||||||||||||
| Net Income | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Other comprehensive (loss) income, net of tax: | |||||||||||||||||||||||
| Foreign currency translation adjustments |
(
|
|
(
|
|
|||||||||||||||||||
| Pension and postretirement liability adjustments |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Change in fair value of marketable securities |
|
(
|
|
|
|||||||||||||||||||
| Change in fair value of derivative financial instruments |
|
(
|
|
(
|
|||||||||||||||||||
| Other comprehensive (loss) income, net of tax |
(
|
|
(
|
|
|||||||||||||||||||
| Comprehensive Income, net of tax |
|
|
|
|
|||||||||||||||||||
| Less: comprehensive income (loss) attributable to noncontrolling interest |
|
|
|
(
|
|||||||||||||||||||
| Comprehensive Income Attributable to The Timken Company | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
See accompanying Notes to the Consolidated Financial Statements.
1
Consolidated Balance Sheets
| (Unaudited) | |||||||||||
| (Dollars in millions) |
September 30,
2021 |
December 31,
2020 |
|||||||||
| ASSETS | |||||||||||
| Current Assets | |||||||||||
| Cash and cash equivalents | $ |
|
$ |
|
|||||||
| Restricted cash |
|
|
|||||||||
|
Accounts receivable, less allowances (2021 – $
|
|
|
|||||||||
| Unbilled receivables |
|
|
|||||||||
| Inventories, net |
|
|
|||||||||
| Deferred charges and prepaid expenses |
|
|
|||||||||
| Other current assets |
|
|
|||||||||
| Total Current Assets |
|
|
|||||||||
| Property, Plant and Equipment, net |
|
|
|||||||||
| Other Assets | |||||||||||
| Goodwill |
|
|
|||||||||
| Other intangible assets |
|
|
|||||||||
| Operating lease assets |
|
|
|||||||||
| Non-current pension assets |
|
|
|||||||||
| Deferred income taxes |
|
|
|||||||||
| Other non-current assets |
|
|
|||||||||
| Total Other Assets |
|
|
|||||||||
| Total Assets | $ |
|
$ |
|
|||||||
| LIABILITIES AND EQUITY | |||||||||||
| Current Liabilities | |||||||||||
| Short-term debt | $ |
|
$ |
|
|||||||
| Current portion of long-term debt |
|
|
|||||||||
| Short-term operating lease liabilities |
|
|
|||||||||
| Accounts payable, trade |
|
|
|||||||||
| Salaries, wages and benefits |
|
|
|||||||||
| Income taxes payable |
|
|
|||||||||
| Other current liabilities |
|
|
|||||||||
| Total Current Liabilities |
|
|
|||||||||
| Non-Current Liabilities | |||||||||||
| Long-term debt |
|
|
|||||||||
| Accrued pension benefits |
|
|
|||||||||
| Accrued postretirement benefits |
|
|
|||||||||
| Long-term operating lease liabilities |
|
|
|||||||||
| Deferred income taxes |
|
|
|||||||||
| Other non-current liabilities |
|
|
|||||||||
| Total Non-Current Liabilities |
|
|
|||||||||
| Shareholders’ Equity | |||||||||||
| Class I and II Serial Preferred Stock, without par value: | |||||||||||
|
Authorized –
|
|
|
|||||||||
| Common shares, without par value: | |||||||||||
|
Authorized –
|
|||||||||||
|
Issued (including shares in treasury) (2021 –
|
|||||||||||
| Stated capital |
|
|
|||||||||
| Other paid-in capital |
|
|
|||||||||
| Retained earnings |
|
|
|||||||||
| Accumulated other comprehensive (loss) income |
(
|
|
|||||||||
|
Treasury shares at cost (2021 –
|
(
|
(
|
|||||||||
| Total Shareholders’ Equity |
|
|
|||||||||
| Noncontrolling Interest |
|
|
|||||||||
| Total Equity |
|
|
|||||||||
| Total Liabilities and Equity | $ |
|
$ |
|
|||||||
See accompanying Notes to the Consolidated Financial Statements.
2
Consolidated Statements of Cash Flows
(Unaudited)
|
Nine Months Ended
September 30, |
|||||||||||
| 2021 | 2020 | ||||||||||
| (Dollars in millions) | |||||||||||
| CASH PROVIDED (USED) | |||||||||||
| Operating Activities | |||||||||||
| Net income | $ |
|
$ |
|
|||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Depreciation and amortization |
|
|
|||||||||
| Impairment charges |
|
|
|||||||||
| Loss on sale of assets |
|
|
|||||||||
| Acquisition-related gain |
(
|
|
|||||||||
| Deferred income tax benefit |
(
|
(
|
|||||||||
| Stock-based compensation expense |
|
|
|||||||||
| Pension and other postretirement benefit expense (income) |
|
(
|
|||||||||
| Pension and other postretirement benefit contributions and payments |
(
|
(
|
|||||||||
| Changes in operating assets and liabilities: | |||||||||||
| Accounts receivable |
(
|
(
|
|||||||||
| Unbilled receivables |
|
(
|
|||||||||
| Inventories |
(
|
|
|||||||||
| Accounts payable, trade |
|
|
|||||||||
| Other accrued expenses |
|
|
|||||||||
| Income taxes |
(
|
|
|||||||||
| Other, net |
(
|
|
|||||||||
| Net Cash Provided by Operating Activities |
|
|
|||||||||
| Investing Activities | |||||||||||
| Capital expenditures |
(
|
(
|
|||||||||
| Acquisitions, net of cash received |
(
|
(
|
|||||||||
| Investments in short-term marketable securities, net |
(
|
(
|
|||||||||
| Other, net |
|
|
|||||||||
| Net Cash Used in Investing Activities |
(
|
(
|
|||||||||
| Financing Activities | |||||||||||
| Cash dividends paid to shareholders |
(
|
(
|
|||||||||
| Purchase of treasury shares |
(
|
(
|
|||||||||
| Proceeds from exercise of stock options |
|
|
|||||||||
| Payments related to tax withholding for stock-based compensation |
(
|
(
|
|||||||||
| Borrowings on accounts receivable facility |
|
|
|||||||||
| Payments on accounts receivable facility |
(
|
(
|
|||||||||
| Proceeds from long-term debt |
|
|
|||||||||
| Payments on long-term debt |
(
|
(
|
|||||||||
| Deferred financing costs |
|
(
|
|||||||||
| Short-term debt activity, net |
(
|
|
|||||||||
| Noncontrolling interest dividends paid |
(
|
(
|
|||||||||
| Net Cash Used in Financing Activities |
(
|
(
|
|||||||||
| Effect of exchange rate changes on cash |
(
|
(
|
|||||||||
| (Decrease) Increase in Cash, Cash Equivalents and Restricted Cash |
(
|
|
|||||||||
| Cash, cash equivalents and restricted cash at beginning of year |
|
|
|||||||||
| Cash, Cash Equivalents and Restricted Cash at End of Period | $ |
|
$ |
|
|||||||
See accompanying Notes to the Consolidated Financial Statements.
3
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
(Dollars in millions, except per share data)
Note 2 - Significant Accounting Policies
The Company's significant accounting policies are detailed in "
Note 1 - Significant Accounting Policies"
of the Annual Report on Form 10-K for the year ended December 31, 2020.
Recent Accounting Pronouncements:
New Accounting Guidance Adopted:
In December 2019, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2019-12, “Income Taxes (ASC 740) – Simplifying the Accounting for Income Taxes,” which is intended to reduce complexity in the accounting for income taxes while maintaining or improving the usefulness of information provided to financial statement users. The guidance amends certain existing provisions under ASC 740 to address a number of distinct items. This standard is effective for public companies in fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company adopted ASU 2019-12 effective January 1, 2021, and the impact of the adoption was not material to the Company's results of operations and financial condition.
New Accounting Guidance Issued and Not Yet Adopted:
4
Note 3 - Acquisitions
On
August 20, 2021
, the Company completed the acquisition of the assets of Intelligent Machine Solutions ("iMS"), a manufacturer of industrial robotics and automation solutions, with annual sales of approximately $
6.0
million. iMS is headquartered in Norton Shores, Michigan. The purchase price due at closing for this acquisition was
$
7.4
million, subject to customary post-closing adjustments. In addition, the seller has the opportunity to earn
$
3.0
million of contingent performance-based consideration between January 1, 2022 and June 30, 2024. This additional component will be accounted for as compensation expense over that period because the payment is contingent in part upon the continued employment of a former executive of the seller. Based on markets and customers served, results for iMS are primarily reported in the Process Industries segment.
The following table presents the purchase price allocation at fair value for the iMS acquisition:
| Initial Purchase Price Allocation | |||||
| Total assets acquired | $ |
|
|||
| Total liabilities assumed |
|
||||
| Net assets acquired | $ |
|
|||
In determining the fair value of the amounts above, the Company utilized various forms of the income, cost and market approaches depending on the asset or liability being valued. The estimation of fair value required significant judgment related to future net cash flows, discount rates, competitive trends, market comparisons and other factors. Inputs were generally determined by taking into account independent appraisals and historical data, supplemented by current and anticipated market conditions.
The amounts in the table above represent the preliminary purchase price allocation for iMS. This purchase price allocation is based on preliminary information and is subject to change as additional information concerning final asset and liability valuations are obtained. As of September 30, 2021, no elements of the purchase price allocation have been finalized. During the applicable measurement period, the Company will adjust assets and liabilities if new information is obtained about facts and circumstances that existed as of the acquisition date that, if known, would have resulted in revised estimated values of those assets or liabilities as of that date. The effect of measurement period adjustments to the estimated fair values will be reflected as if the adjustments had been completed on the acquisition date. The above purchase price allocation is subject to change as additional information concerning final asset and liability valuations is obtained.
On
November 30, 2020
, the Company completed the acquisition of the assets of Aurora Bearing Company ("Aurora"). With annual sales of approximately $
30
million, Aurora serves a diverse range of industrial sectors, including aerospace and defense, racing, off-highway equipment and packaging. Aurora is headquartered in Montgomery, Illinois. The total purchase price for this acquisition was $
17.2
million, including a post-closing net working capital adjustment. Based on markets and customers served, results for Aurora are reported in both the Mobile Industries segment and the Process Industries segment.
5
Note 3 - Acquisitions (continued)
The following table presents the purchase price allocation at fair value, net of cash acquired, for the Aurora acquisition as of September 30, 2021:
|
Initial Purchase
Price Allocation |
Adjustments |
Final Purchase
Price Allocation |
|||||||||
| Assets: | |||||||||||
| Accounts receivable | $ |
|
$ |
|
$ |
|
|||||
| Inventories |
|
|
|
||||||||
| Other current assets |
|
|
|
||||||||
| Property, plant and equipment |
|
|
|
||||||||
| Total assets acquired | $ |
|
$ |
|
$ |
|
|||||
| Liabilities: | |||||||||||
| Accounts payable, trade | $ |
|
$ |
|
$ |
|
|||||
| Other current liabilities |
|
(
|
|
||||||||
| Total liabilities assumed |
|
(
|
|
||||||||
| Net assets acquired | $ |
|
$ |
|
$ |
|
|||||
6
Note 4 - Revenue
The following table presents details deemed most relevant to the users of the financial statements about total revenue for the three and nine months ended September 30, 2021 and 2020, respectively:
| Three Months Ended | Three Months Ended | |||||||||||||||||||
| September 30, 2021 | September 30, 2020 | |||||||||||||||||||
| Mobile | Process | Total | Mobile | Process | Total | |||||||||||||||
| United States | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||
| Americas, excluding the United States |
|
|
|
|
|
|
||||||||||||||
| Europe / Middle East / Africa |
|
|
|
|
|
|
||||||||||||||
| China |
|
|
|
|
|
|
||||||||||||||
| Asia-Pacific, excluding China |
|
|
|
|
|
|
||||||||||||||
| Net sales | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||
| Nine Months Ended | Nine Months Ended | |||||||||||||||||||
| September 30, 2021 | September 30, 2020 | |||||||||||||||||||
| Mobile | Process | Total | Mobile | Process | Total | |||||||||||||||
| United States | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||
| Americas, excluding the United States |
|
|
|
|
|
|
||||||||||||||
| Europe / Middle East / Africa |
|
|
|
|
|
|
||||||||||||||
| China |
|
|
|
|
|
|
||||||||||||||
| Asia-Pacific, excluding China |
|
|
|
|
|
|
||||||||||||||
| Net sales | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||
When reviewing revenue by sales channel, the Company separates net sales to original equipment manufacturers ("OEMs") from sales to distributors and end users. The following table presents the percent of revenue by sales channel for the nine months ended September 30, 2021 and 2020, respectively:
| Nine Months Ended | ||||||||
| Revenue by sales channel | September 30, 2021 | September 30, 2020 | ||||||
| Original equipment manufacturers |
|
|
||||||
| Distribution/end users |
|
|
||||||
In addition to disaggregating revenue by segment, geography and by sales channel as shown above, the Company believes information about the timing of transfer of goods or services, type of customer and distinguishing service revenue from product sales is also relevant. During the nine months ended September 30, 2021 and September 30, 2020, approximately
8
% and
12
%, respectively, of total net sales were recognized on an over-time basis because of the continuous transfer of control to the customer, with the remainder recognized as of a point in time. Approximately
4
%
and
5
% of total net sales represented service revenue during each of the nine months ended September 30, 2021 and September 30, 2020, respectively. Finally, the United States ("U.S.") government or its contractors represented approximately
7
% and
9
% of total net sales during the nine months ended September 30, 2021 and September 30, 2020, respectively.
Remaining Performance Obligations:
Remaining performance obligations represent the transaction price of orders meeting the definition of a contract for which work has not been performed and excludes unexercised contract options. Performance obligations having a duration of more than one year are concentrated in contracts for certain products and services provided to the U.S. government or its contractors. The aggregate amount of the transaction price allocated to remaining performance obligations for such contracts with a duration of more than one year was approximately $
417.8
million
a
t September 30, 2021.
7
Note 4 - Revenue
(continued)
Unbilled Receivables:
The following table contains a rollforward of unbilled receivables for the nine months ended September 30, 2021 and the twelve months ended December 31, 2020:
|
September 30,
2021 |
December 31,
2020 |
|||||||
| Beginning balance, January 1 | $ |
|
$ |
|
||||
| Additional unbilled revenue recognized |
|
|
||||||
| Less: amounts billed to customers |
(
|
(
|
||||||
| Ending balance | $ |
|
$ |
|
||||
There were no impairment losses recorded on unbilled receivables for the nine months ended September 30, 2021 and September 30, 2020, respectively.
Note 5 - Segment Information
The primary measurement used by management to measure the financial performance of each segment is earnings before interest, taxes, depreciation and amortization ("EBITDA").
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
||||||||||||||||||||||
| 2021 | 2020 | 2021 | 2020 | ||||||||||||||||||||
| Net sales: | |||||||||||||||||||||||
| Mobile Industries | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Process Industries |
|
|
|
|
|||||||||||||||||||
| Net sales | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Segment EBITDA: | |||||||||||||||||||||||
| Mobile Industries | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Process Industries |
|
|
|
|
|||||||||||||||||||
| Total EBITDA, for reportable segments | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Unallocated corporate expense |
(
|
(
|
(
|
(
|
|||||||||||||||||||
|
Corporate pension and other postretirement benefit
related (expense) income
(1)
|
(
|
|
(
|
|
|||||||||||||||||||
|
Acquisition-related gain
(2)
|
|
|
|
|
|||||||||||||||||||
| Depreciation and amortization |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Interest expense |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Interest income |
|
|
|
|
|||||||||||||||||||
| Income before income taxes | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
(1)
Corporate pension and other postretirement benefit related (expense) income represents actuarial (losses) and gains that resulted from the remeasurement of pension and other postretirement plan assets and obligations as a result of changes in assumptions or experience.
(2)
The acquisition-related gain represents measurement period adjustments to the bargain purchase gain on the acquisition of Aurora, which closed on November 30, 2020. See
Note 3 - Acquisitions
for additional information.
8
Note 6 - Income Taxes
The Company's provision for income taxes in interim periods is computed by applying the estimated annual effective tax rates to income or loss before income taxes for the period. In addition, non-recurring or discrete items are recorded during the period(s) in which they occur.
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||||||||
| 2021 | 2020 | 2021 | 2020 | |||||||||||||||||
| Provision for income taxes | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||
| Effective tax rate |
|
% |
|
% |
|
% |
|
% | ||||||||||||
Income tax expense for the three and nine months ended September 30, 2021 was calculated using forecasted multi-jurisdictional annual effective tax rates to determine a blended annual effective tax rate. The effective tax rate differs from the U.S. federal statutory rate of
21
% primarily due to the release of accruals for uncertain tax positions related to the settlement of the 2017 and 2018 U.S. federal tax years and adjustments in other foreign jurisdictions, and favorable U.S. permanent book-tax differences. These items were partially offset by the unfavorable impact of earnings in foreign jurisdictions with higher tax rates.
The effective tax rate of
18.2
% for the three months ended September 30, 2021 was lower than the rate for the three months ended September 30, 2020 primarily due to the release of accruals for uncertain tax positions and favorable U.S. permanent book-tax differences, including the new elective Global Intangible Low Tax Income ("GILTI") high tax exemption rules. These impacts were partially offset by a greater percentage of earnings in higher tax rate jurisdictions.
The effective tax rate of
19.3
% for the nine months ended September 30, 2021 was lower than the rate for the nine months ended September 30, 2020 primarily due to the release of accruals for uncertain tax positions and favorable U.S. permanent book-tax differences, including the tax impact from stock-based compensation awards and the new elective GILTI high tax exemption rules. These impacts were partially offset by a greater percentage of earnings in higher tax rate jurisdictions.
9
Note 7 - Earnings Per Share
The following table sets forth the reconciliation of the numerator and the denominator of basic earnings per share and diluted earnings per share for the three and nine months ended September 30, 2021 and 2020, respectively:
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
||||||||||||||||||||||
| 2021 | 2020 | 2021 | 2020 | ||||||||||||||||||||
| Numerator: | |||||||||||||||||||||||
| Net income attributable to The Timken Company | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Less: undistributed earnings allocated to nonvested stock |
|
|
|
|
|||||||||||||||||||
|
Net income available to common shareholders for basic
and diluted earnings per share |
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Denominator: | |||||||||||||||||||||||
| Weighted average number of shares outstanding - basic |
|
|
|
|
|||||||||||||||||||
| Effect of dilutive securities: | |||||||||||||||||||||||
|
Stock options and awards - based on the treasury
stock method |
|
|
|
|
|||||||||||||||||||
|
Weighted average number of shares outstanding assuming
dilution of stock options and awards |
|
|
|
|
|||||||||||||||||||
| Basic earnings per share | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Diluted earnings per share | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
The dilutive effect of stock options and awards includes all outstanding stock options and awards except stock options that are considered antidilutive. Stock options are antidilutive when the exercise price exceeds the average market price of the Company’s common shares during the periods presented. The antidilutive stock options outstanding during the three months ended September 30, 2021 and 2020 were
zero
. The antidilutive stock options outstanding during the nine months ended September 30, 2021 and 2020 were
zero
and
902,169
,
respectively.
Note 8 - Inventories
The components of inventories at September 30, 2021 and December 31, 2020 were as follows:
|
September 30,
2021 |
December 31,
2020 |
||||||||||
| Manufacturing supplies | $ |
|
$ |
|
|||||||
| Raw materials |
|
|
|||||||||
| Work in process |
|
|
|||||||||
| Finished products |
|
|
|||||||||
| Subtotal |
|
|
|||||||||
| Allowance for obsolete and surplus inventory |
(
|
(
|
|||||||||
| Total Inventories, net | $ |
|
$ |
|
|||||||
Inventories are valued at net rea
lizable value, with approximately
60
% valued on the first-in, first-out ("FIFO") method and the remaining
40
% v
alued on the last-in, first-out ("LIFO") method. The majority of the Company's domestic inventories are valued on the LIFO method, and all the Company's international inventories are valued on the FIFO method.
The LIFO reserve at September 30, 2021 and December 31, 2020
was
$
191.0
million and $
172.1
million, respectively. An actual valuation of the inventory under the LIFO method can be made only at the end of each year based on the inventory levels and costs at that time. Accordingly, interim LIFO calculations must be based on management’s estimates of expected year-end inventory levels and costs. Because these calculations are subject to many factors beyond management’s control, annual results may differ from interim results as they are subject to the final year-end LIFO inventory valuation.
10
Note 9 - Goodwill and Other Intangible Assets
The changes in the carrying amount of goodwill for the nine months ended September 30, 2021 were as follows:
|
Mobile
Industries |
Process
Industries |
Total | |||||||||
| Beginning balance | $ |
|
$ |
|
$ |
|
|||||
| Acquisitions |
|
|
|
||||||||
| Foreign currency translation adjustments and other changes |
(
|
(
|
(
|
||||||||
| Ending balance | $ |
|
$ |
|
$ |
|
|||||
The acquisition of iMS added $
5.8
million of goodwill. The goodwill for iMS is expected to be 100% tax deductible.
The following table displays intangible assets as of September 30, 2021 and December 31, 2020:
| Balance at September 30, 2021 | Balance at December 31, 2020 | |||||||||||||||||||
|
Gross
Carrying Amount |
Accumulated
Amortization |
Net
Carrying Amount |
Gross
Carrying Amount |
Accumulated
Amortization |
Net
Carrying Amount |
|||||||||||||||
|
Intangible assets
subject to amortization: |
||||||||||||||||||||
| Customer relationships | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
||||||||
| Technology and know-how |
|
(
|
|
|
(
|
|
||||||||||||||
| Trade names |
|
(
|
|
|
(
|
|
||||||||||||||
| Capitalized software |
|
(
|
|
|
(
|
|
||||||||||||||
| Other |
|
(
|
|
|
(
|
|
||||||||||||||
| $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||
| Intangible assets not subject to amortization: | ||||||||||||||||||||
| Trade names | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||
| FAA air agency certificates |
|
|
|
|
||||||||||||||||
| $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||
| Total intangible assets | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
||||||||
Amortization expense for intangible assets was $
41.7
million and $
42.1
million for the nine months ended September 30, 2021 and 2020, respectively. Amortization expense for intangible assets is projected to be $
54.9
million in 2021; $
49.1
million in 2022; $
46.0
million in 2023; $
43.9
million in 2024; and $
42.8
million in 2025. Substantially all amortization expense for intangible assets is recorded in Cost of product sold on the Consolidated Statement of Income.
11
Note 10 - Financing Arrangements
Short-term debt at September 30, 2021 and December 31, 2020 was as follows:
|
September 30,
2021 |
December 31,
2020 |
|||||||
|
Variable-rate Accounts Receivable Facility with an interest rate of
|
$ |
|
$ |
|
||||
|
Borrowings under lines of credit for certain of the Company’s foreign subsidiaries with various banks with interest rates ranging fro
m
|
|
|
||||||
| Short-term debt | $ |
|
$ |
|
||||
The Company has a $
100
million Amended and Restated Asset Securitization Agreement (the "Accounts Receivable Facility"), which matures on
November 30, 2021
. The Company intends to renew the Accounts Receivable Facility prior to its maturity. Under the terms of the Accounts Receivable Facility, the Company sells, on an ongoing basis, certain domestic trade receivables to Timken Receivables Corporation, a wholly-owned consolidated subsidiary that, in turn, uses the trade receivables to secure borrowings that are funded through a vehicle that issues commercial paper in the short-term market. Borrowings under the Accounts Receivable Facility may be
limited to certain borrowing base limitations; however, availability under the Accounts Receivable Facility was not reduced by any such borrowing base limitations at September 30, 2021. As of September 30, 2021, there were
no
outstanding borrowings under the Accounts Receivable Facility. The cost
of this facility, which is the prevailing commercial paper rate plus facility fees, is considered a financing cost and is included in interest expense in the Consolidated Statements of Income.
The lines of credit for certain of the Company's foreign subsidiaries provide for short-term borrowings up to $
287.4
million in the aggregate. Most of these lines of credit are uncommitted. At September 30, 2021, the Company’s foreign subsidiaries had borrowings outstanding of $
27.9
million and bank guarantees of $
0.5
million, which reduced the aggregate availability under these facilities to $
259.0
million.
Long-term debt at September 30, 2021 and December 31, 2020 was as follows:
|
September 30,
2021 |
December 31,
2020 |
|||||||
|
Variable-rate Senior Credit Facility with an average interest rate on U.S. Dollar of
|
$ |
|
$ |
|
||||
|
Variable-rate Term Loan
(1)
, maturing on
|
|
|
||||||
|
Fixed-rate Senior Unsecured Notes
(1)
, maturing on
|
|
|
||||||
|
Fixed-rate Euro Senior Unsecured Notes
(1)
, maturing on
|
|
|
||||||
|
Fixed-rate Senior Unsecured Notes
(1)
, maturing on
|
|
|
||||||
|
Fixed-rate Medium-Term Notes, Series A
(1)
, maturing at various dates through May 2028, with interest rates ranging from
|
|
|
||||||
|
Fixed-rate Bank Loan, maturing on
|
|
|
||||||
| Other |
|
|
||||||
| Total debt | $ |
|
$ |
|
||||
| Less: Current maturities |
|
|
||||||
| Long-term debt | $ |
|
$ |
|
||||
(1)
Net of discounts and fees
12
Note 10 - Financing Arrangements (continued)
The Company entered into the Fourth Amended and Restated Credit Agreement ("Senior Credit Facility") on
June 25, 2019
. The Senior Credit Facility is a
$
650.0
million
unsecured revolving credit facility, which matures on
June 25, 2024
. At September 30, 2021, the Co
mpany had $
9.2
million of outstanding borrowings under the Senior Credit Facility, which reduced the availability under this facility to $
640.8
million.
The Senior Credit Facility has two financial covenants: a consolidated leverage ratio and a consolidated interest coverage ratio. On May 27, 2020, the Senior Credit Facility was amended to, among other things, effectively increase the limit with respect to the consolidated leverage ratio. As amended, the consolidated leverage ratio was calculated using a net debt construct, netting unrestricted cash in excess of $
25
million, instead of total debt. The change to the consolidated leverage ratio calculation was effective through June 30, 2021. In the third quarter of 2021, the calculation of the consolidated leverage ratio under the Senior Credit Facility reverted back to a total debt construct.
On
September 11, 2018
, the Company entered into a $
350
million variable-rate term loan that matures on
September 11, 2023
(the "2023 Term Loan"). Proceeds from the 2023 Term Loan were used to fund the acquisitions of Apiary Investments Holding Limited and Rollon S.p.A., which closed on
September 1, 2018
and
September 18, 2018
, respectively. On
July 12, 2019
, the Company amended the
2023 Term Loan agreement to, among other things, align covenants and other terms with the Senior Credit Facility. On May 27, 2020, the 2023 Term Loan agreement was further amended to align the calculation of the consolidated leverage ratio and other terms with the Senior Credit Facility. The change to the consolidated leverage ratio calculation was effective through June 30, 2021. In the third quarter of 2021, the calculation of the consolidated leverage ratio under the 2023 Term Loan reverted back to a total debt construct.
At September 30, 2021, the Company was in full compliance with all applicable covenants on its outstanding debt.
In the ordinary course of business, the Company utilizes standby letters of credit issued by financial institutions to guarantee certain obligations, most of which relate to insurance contracts. At September 30, 2021, outstanding letters of credit tot
aled
$
42.5
million,
most with
expiration dates within 12 months.
13
Note 11 - Contingencies
The Company and certain of its subsidiaries have been identified as potentially responsible parties for investigation and remediation under the Comprehensive Environmental Response, Compensation and Liability Act, known as the Superfund, or similar state laws with respect to certain sites. Claims for investigation and remediation have been asserted against numerous other entities, which are believed to be financially solvent and are expected to fulfill their proportionate share of the obligation.
On December 28, 2004, the United States Environmental Protection Agency (“USEPA”) sent Lovejoy, Inc. ("Lovejoy") a Special Notice Letter that identified Lovejoy as a potentially responsible party, together with at least 14 other companies, at the Ellsworth Industrial Park Site, Downers Grove, DuPage County, Illinois (the “Site”). The Company acquired Lovejoy in 2016. Lovejoy’s Downers Grove property is situated within the Ellsworth Industrial Complex. The USEPA and the Illinois Environmental Protection Agency (“IEPA”) allege there have been one or more releases or threatened releases of hazardous substances, allegedly including, but not limited to, a release or threatened release on or from Lovejoy's property, at the Site. The relief sought by the USEPA and IEPA includes further investigation and potential remediation of the Site and reimbursement of response costs. Lovejoy’s allocated share of past and future costs related to the Site, including for investigation and/or remediation, could be significant. All previously pending property damage and personal injury lawsuits against Lovejoy related to the Site were settled or dismissed prior to our acquisition of Lovejoy.
The Company had total environmental accruals of $
5.2
million and $
5.3
million for various known environmental matters that are probable and reasonably estimable at September 30, 2021
and
December 31, 2020, respectively, which includes the Lovejoy matter described above. These accruals were recorded based upon the best estimate of costs to be incurred in light of the progress made in determining the magnitude of remediation costs, the timing and extent of remedial actions required by governmental authorities and the amount of the Company’s liability in proportion to other responsible parties.
Product Warranties:
In addition to the contingencies above, the Company provides limited warranties on certain of its products. The product warranty liability included in "Other current liabilities" on the Consolidated Balance Sheets was $
11.5
million
and $
9.4
million at September 30, 2021 and December 31, 2020, respectively. The increase in the liability since year end primarily relates to accruals that are based on the best estimate of costs for future claims based on products sold that are still under warranty. The estimate of these accruals is based on historical claims and expected trends that continue to mature. Any significant change to these assumptions may be material to the results of operations in any particular period in which that change occurs.
The following is a rollforward of the consolidated product warranty accrual for the nine months ended September 30, 2021 and twelve months ended December 31, 2020:
|
September 30,
2021 |
December 31,
2020 |
|||||||
| Beginning balance, January 1 | $ |
|
$ |
|
||||
| Expense |
|
|
||||||
| Payments |
(
|
(
|
||||||
| Ending balance | $ |
|
$ |
|
||||
14
Note 12 - Equity
The following tables present the changes in the components of equity for the three and nine months ended September 30, 2021 and 2020, respectively:
| The Timken Company Shareholders | |||||||||||||||||||||||
| Total |
Stated
Capital |
Other
Paid-In Capital |
Retained Earnings |
Accumulated
Other Comprehensive Income (Loss) |
Treasury
Stock |
Non
controlling Interest |
|||||||||||||||||
| Balance at June 30, 2021 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||
| Net income |
|
|
|
||||||||||||||||||||
| Foreign currency translation adjustment |
(
|
(
|
|
||||||||||||||||||||
|
Pension and other postretirement liability
adjustments (net of income tax benefit
of $
|
(
|
(
|
|||||||||||||||||||||
|
Change in fair value of derivative financial
instruments, net of reclassifications |
|
|
|||||||||||||||||||||
| Dividends declared to noncontrolling interest |
(
|
(
|
|||||||||||||||||||||
|
Dividends – $
|
(
|
(
|
|||||||||||||||||||||
| Stock-based compensation expense |
|
|
|||||||||||||||||||||
| Stock purchased at fair market value |
(
|
(
|
|||||||||||||||||||||
| Balance at September 30, 2021 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||
| The Timken Company Shareholders | |||||||||||||||||||||||
| Total |
Stated
Capital |
Other
Paid-In Capital |
Retained Earnings |
Accumulated
Other Comprehensive Income (Loss) |
Treasury
Stock |
Non
controlling Interest |
|||||||||||||||||
| Balance at December 31, 2020 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||
| Net income |
|
|
|
||||||||||||||||||||
| Foreign currency translation adjustment |
(
|
(
|
(
|
||||||||||||||||||||
|
Pension and other postretirement liability
adjustments (net of income tax benefit
of $
|
(
|
(
|
|||||||||||||||||||||
|
Change in fair value of derivative financial
instruments, net of reclassifications |
|
|
|||||||||||||||||||||
| Dividends declared to noncontrolling interest |
(
|
(
|
|||||||||||||||||||||
|
Dividends – $
|
(
|
(
|
|||||||||||||||||||||
| Stock-based compensation expense |
|
|
|||||||||||||||||||||
| Stock purchased at fair market value |
(
|
(
|
|||||||||||||||||||||
| Stock option exercise activity |
|
|
|||||||||||||||||||||
|
Payments related to tax withholding for
stock-based compensation |
(
|
(
|
|||||||||||||||||||||
| Balance at September 30, 2021 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||
15
Note 12 - Equity (continued)
| The Timken Company Shareholders | |||||||||||||||||||||||
| Total |
Stated
Capital |
Other
Paid-In Capital |
Retained Earnings |
Accumulated
Other Comprehensive (Loss) |
Treasury
Stock |
Non
controlling Interest |
|||||||||||||||||
| Balance at June 30, 2020 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||
| Net income |
|
|
|
||||||||||||||||||||
| Foreign currency translation adjustment |
|
|
|
||||||||||||||||||||
|
Pension and other postretirement liability
adjustments (net of income tax benefit
of $
|
(
|
(
|
|||||||||||||||||||||
| Unrealized gain on marketable securities |
(
|
(
|
|||||||||||||||||||||
|
Change in fair value of derivative financial
instruments, net of reclassifications |
(
|
(
|
|||||||||||||||||||||
| Dividends declared to noncontrolling interest |
(
|
(
|
|||||||||||||||||||||
|
Dividends – $
|
(
|
(
|
|||||||||||||||||||||
| Stock-based compensation expense |
|
|
|||||||||||||||||||||
| Stock option exercise activity |
|
(
|
|
||||||||||||||||||||
| Restricted share activity |
|
(
|
|
||||||||||||||||||||
|
Payments related to tax withholding for
stock-based compensation |
(
|
(
|
|||||||||||||||||||||
| Balance at September 30, 2020 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||
| The Timken Company Shareholders | |||||||||||||||||||||||
| Total |
Stated
Capital |
Other
Paid-In Capital |
Retained Earnings |
Accumulated
Other Comprehensive (Loss) |
Treasury
Stock |
Non
controlling Interest |
|||||||||||||||||
| Balance at December 31, 2019 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||
|
Cumulative effect of ASU 2016-13
(net of income tax benefit of $
|
(
|
(
|
|||||||||||||||||||||
| Net income |
|
|
|
||||||||||||||||||||
| Foreign currency translation adjustment |
|
|
(
|
||||||||||||||||||||
|
Pension and other postretirement liability
adjustments (net of income tax benefit
of $
|
(
|
(
|
|||||||||||||||||||||
|
Change in fair value of derivative financial
instruments, net of reclassifications |
(
|
(
|
|||||||||||||||||||||
|
Change in ownership of noncontrolling
interest |
|
|
|||||||||||||||||||||
| Dividends declared to noncontrolling interest |
(
|
(
|
|||||||||||||||||||||
|
Dividends – $
|
(
|
(
|
|||||||||||||||||||||
| Stock-based compensation expense |
|
|
|||||||||||||||||||||
| Stock purchased at fair market value |
(
|
(
|
|||||||||||||||||||||
| Stock option exercise activity |
|
(
|
|
||||||||||||||||||||
| Restricted share activity |
|
(
|
|
||||||||||||||||||||
|
Payments related to tax withholding for
stock-based compensation |
(
|
(
|
|||||||||||||||||||||
| Balance at September 30, 2020 | $ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||
16
Note 13 - Impairment and Restructuring Charges
Impairment and restructuring charges by segment are comprised of the following:
For the three months ended September 30, 2021:
| Mobile Industries | Process Industries | Unallocated Corporate | Total | |||||||||||
| Severance and related benefit costs | $ |
|
$ |
|
$ |
|
$ |
|
||||||
| Exit costs |
|
|
|
|
||||||||||
| Total | $ |
|
$ |
|
$ |
|
$ |
|
||||||
For the nine months ended September 30, 2021:
| Mobile Industries | Process Industries | Unallocated Corporate | Total | |||||||||||
| Impairment charges | $ |
|
$ |
|
$ |
|
$ |
|
||||||
| Severance and related benefit costs |
|
|
|
|
||||||||||
| Exit costs |
|
|
|
|
||||||||||
| Total | $ |
|
$ |
|
$ |
|
$ |
|
||||||
For the three months ended September 30, 2020:
| Mobile Industries | Process Industries | Unallocated Corporate | Total | |||||||||||
| Severance and related benefit costs | $ |
|
$ |
|
$ |
|
$ |
|
||||||
| Exit costs |
|
|
|
|
||||||||||
| Total | $ |
|
$ |
|
$ |
|
$ |
|
||||||
For the nine months ended September 30, 2020:
| Mobile Industries | Process Industries | Unallocated Corporate | Total | |||||||||||
| Impairment charges | $ |
|
$ |
|
$ |
|
$ |
|
||||||
| Severance and related benefit costs |
|
|
|
|
||||||||||
| Exit costs |
|
|
|
|
||||||||||
| Total | $ |
|
$ |
|
$ |
|
$ |
|
||||||
The following discussion explains the impairment and restructuring charges recorded for the periods presented; however, it is not intended to reflect a comprehensive discussion of all amounts in the tables above.
Coronavirus ("COVID-19") Pandemic Cost Reduction Initiatives:
During the three months and nine months ended
September 30, 2020
, the Company recorded $
9.5
million and $
11.5
million, respectively, in severance and related benefit costs to eliminate approximately
200
salaried positions to align then current employment levels with customer demand. Of the $
9.5
million charge, $
4.9
million related to the Mobile Industries segment, $
4.2
million related to the Process Industries segment and $
0.4
million related to Unallocated Corporate. Of the $
11.5
million charge, $
5.5
million related to the Mobile Industries segment, $
5.6
million related to the Process Industries segment and $
0.4
million related to Unallocated Corporate.
17
Note 13 - Impairment and Restructuring Charges (continued)
Mobile Industries:
On July 19, 2021, the Company announced the closure of its bearing manufacturing facility in Villa Carcina, Italy. The Company will be transferring the man
ufacturing of its single-row tapered roller bearing production to other bearing facilities in Europe, Asia and the United States. The Company expects to complete the closure by June of 2022
and is expected to affect approximately
110
employees. The Company expects to incur approximately $
9
million to $
11
million of expenses related to this closure. During the t
hree months ended September 30, 2021, the Company recorded $
2.2
million in severance and related benefits related to this closure. A
head of this announcement, the Company reviewed assets for impairment. As a result, the Company recorded impairment charges of $
1.0
million during the three months ended June 30, 2021. The Company has incurred cumulative pretax costs related to this closure of $
5.4
million as of September 30, 2021, including rationalization costs recorded in cost of products sold.
On October 16, 2019, the Company announced the reorganization of its bearing manufacturing facility in Gaffney, South Carolina. The Company transferred its high-volume bearing production and roller production to other Timken manufacturing facilities in the United States. The transfer of these operations was substantially completed by the end of the third quarter of 2020 and affected approximately
150
employees. The Company expected to incur approximately $
8
million to $
10
million of pretax costs in total related to this reorganization. During the nine months ended September 30, 2020, the Company recognized severance and related benefits of $
0.3
million and exit costs of $
0.4
million related to this reorganization. The Company incurred cumulative pretax costs related to this reorganization of $
7.8
million as of September 30, 2021, including rationalization costs recorded in cost of products sold.
Process Industries:
On February 4, 2020, the Company announced the closure of its chain manufacturing facility in Indianapolis, Indiana. This facility was part of the Diamond Chain Company ("Diamond Chain") acquisition completed on April 1, 2019. The Company will be transferring the manufacturing of its Diamond Chain product line to its chain facility in Fulton, Illinois. The chain plant is expected to cease operations by the end of the fourth quarter of 2021 and is expected to affect approximately
240
employees. The Company expects to hire approximately
130
full-time positions in Fulton, Illinois and expects to incur approximately $
10
million to $
12
million of expenses related to this closure. During the three months ended September 30, 2021 and September 30, 2020, the Company recorded severance and related benefit costs of $
0.3
million and $
0.3
million, respectively, related to this closure. During the nine months ended September 30, 2021 and September 30, 2020, the Company recorded severance and related benefit costs of $
0.9
million and $
2.6
million, respectively, related to this closure. The Company has incurred cumulative pretax costs related to this closure of $
9.6
million as of September 30, 2021, including rationalization costs recorded in cost of products sold.
On September 3, 2020, the Company announced the reorganization of its bearing plant in Canton, Ohio. The Company will be transferring production for certain product lines to other Timken locations in order to streamline resources and better align capacity with demand. The transfer of these operations is expected to occur by 2022 and is expected to affect approximately
40
employees. The Company expects to incur approximately $
2.0
million to $
2.5
million of pretax costs related to this reorganization. During the three months ended
September 30, 2020
, the Company recognized severance and related benefits of $
0.6
million related to this reorganization. The Company has incurred cumulative pretax costs related to this reorganization of $
1.2
million as of
September 30, 2021
, including rationalization costs recorded in cost of products sold.
In addition, the Company recorded impairment charges of $
3.3
million related to certain engineering-related assets used in the business during the
nine
months ended
September 30, 2021
. Management concluded no further investment would be made in these assets and as a result, reduced the value to zero.
18
Note 13 - Impairment and Restructuring Charges (continued)
Consolid
ated Restructuring Accrual:
The following is a rollforward of the consolidated restructuring accrual for the nine months ended September 30, 2021 and twelve months ended December 31, 2020:
|
September 30,
2021 |
December 31,
2020 |
|||||||
| Beginning balance, January 1 | $ |
|
$ |
|
||||
| Expense |
|
|
||||||
| Payments |
(
|
(
|
||||||
| Ending balance | $ |
|
$ |
|
||||
The restructuring accrual at September 30, 2021 was included in other current liabilities on the Consolidated Balance Sheets.
Note 14 - Retirement Benefit Plans
The following table sets forth the net periodic benefit cost for the Company’s defined benefit pension plans. The amounts for the three and nine months ended September 30, 2021 are based on calculations prepared by the Company's actuaries and represent the Company’s best estimate of that period’s proportionate share of the amounts to be recorded for the year ending December 31, 2021.
| U.S. Plans | International Plans | Total | ||||||||||||||||||
|
Three Months Ended
September 30, |
Three Months Ended
September 30, |
Three Months Ended
September 30, |
||||||||||||||||||
| 2021 | 2020 | 2021 | 2020 | 2021 | 2020 | |||||||||||||||
|
Components of net periodic benefit
cost (credit): |
||||||||||||||||||||
| Service cost | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||
| Interest cost |
|
|
|
|
|
|
||||||||||||||
| Expected return on plan assets |
(
|
(
|
(
|
(
|
(
|
(
|
||||||||||||||
| Amortization of prior service cost |
|
|
|
|
|
|
||||||||||||||
|
Recognition of net actuarial losses
(gains) |
|
(
|
|
|
|
(
|
||||||||||||||
| Curtailment loss |
|
|
|
|
|
|
||||||||||||||
| Net periodic benefit cost (credit) | $ |
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
||||||||
| U.S. Plans | International Plans | Total | ||||||||||||||||||
|
Nine Months Ended
September 30, |
Nine Months Ended
September 30, |
Nine Months Ended
September 30, |
||||||||||||||||||
| 2021 | 2020 | 2021 | 2020 | 2021 | 2020 | |||||||||||||||
|
Components of net periodic benefit
cost (credit): |
||||||||||||||||||||
| Service cost | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||
| Interest cost |
|
|
|
|
|
|
||||||||||||||
| Expected return on plan assets |
(
|
(
|
(
|
(
|
(
|
(
|
||||||||||||||
| Amortization of prior service cost |
|
|
|
|
|
|
||||||||||||||
|
Recognition of net actuarial losses
(gains) |
|
(
|
|
|
|
(
|
||||||||||||||
| Curtailment loss |
|
|
|
|
|
|
||||||||||||||
| Net periodic benefit cost (credit) | $ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
$ |
|
||||||||
19
Note 14 - Retirement Benefit Plans (continued)
The Company currently expects to make contributions and payments related to its global defined benefit pension plans totaling approximately $
17
million in 2021. Approximately $
9.6
million of this amount related to the payout of deferred compensation in June 2021 to a former executive officer of the Company. This payment triggered a remeasurement of the pension obligation for one of the Company's U.S. defined benefit pension plans during the six months ended June 30, 2021. No remeasurement was required for this defined benefit pension plan during the three months ended September 30, 2021. In addition, the Company made lump sum payments to new retirees in 2021 in excess of annual interest and service costs for two of its other U.S. defined benefit pension plans. These payments triggered a remeasurement of assets and obligations for these U.S. defined benefit pension plans during the three and nine months ended September 30, 2021. As a result of these remeasurements, the Company recognized net actuarial losses ("remeasurement losses") of $
3.9
million and $
8.3
million during the three and nine months ended September 30, 2021, respectively.
During the
three
months ended
September 30, 2020
, the Company announced the reorganization of its bearing plant in Canton, Ohio. The reorganization triggered a curtailment of one of the Company's U.S. defined benefit pension plans. The Company recognized a curtailment loss of $
0.9
million and an actuarial gain of $
0.7
million as a result of this reorganization.
During the three and nine months ended
September 30, 2020, t
he Company made lump sum payments to new retirees in 2020 in excess of annual interest and service costs for one of the Company's U.S. defined benefit pension plans. This triggered a remeasurement of assets and obligations for this plan during the three and nine months ended
September 30, 2020.
As a result of these remeasurements, the Company recognized actuarial gains of $
12.1
million and $
3.3
million during the three and nine months ended
September 30, 2020
, respectively.
Note 15 - Other Postretirement Benefit Plans
The following table sets forth the net periodic benefit cost for the Company’s other postretirement benefit plans. The amounts for the three and nine months ended September 30, 2021 are based on calculations prepared by the Company's actuaries and represent the Company’s best estimate of that period’s proportionate share of the amounts to be recorded for the year ending December 31, 2021.
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
||||||||||||||||||||||
| 2021 | 2020 | 2021 | 2020 | ||||||||||||||||||||
| Components of net periodic benefit credit: | |||||||||||||||||||||||
| Service cost | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Interest cost |
|
|
|
|
|||||||||||||||||||
| Expected return on plan assets |
|
(
|
|
(
|
|||||||||||||||||||
| Amortization of prior service credit |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Net periodic benefit credit | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||
In January 2021, the Company transferred the remaining $
20
Note 16 - Accumulated Other Comprehensive Income (Loss)
The following tables present details about components of accumulated other comprehensive income (loss) for the three and nine months ended September 30, 2021 and 2020, respectively:
| Foreign currency translation adjustments | Pension and other postretirement liability adjustments | Unrealized gain (loss) on marketable securities | Change in fair value of derivative financial instruments | Total | |||||||||||||
| Balance at June 30, 2021 | $ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||
|
Other comprehensive (loss) income before
reclassifications and income taxes |
(
|
|
|
|
(
|
||||||||||||
|
Amounts reclassified from accumulated other
comprehensive (loss) income before income taxes |
|
(
|
|
|
(
|
||||||||||||
| Income tax benefit (expense) |
|
|
|
(
|
(
|
||||||||||||
|
Net current period other comprehensive (loss)
income, net of income taxes |
(
|
(
|
|
|
(
|
||||||||||||
| Noncontrolling interest |
(
|
|
|
|
(
|
||||||||||||
|
Net current period comprehensive (loss) income,
net of income taxes and noncontrolling interest |
(
|
(
|
|
|
(
|
||||||||||||
| Balance at September 30, 2021 | $ |
(
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|||||||
| Foreign currency translation adjustments | Pension and other postretirement liability adjustments | Unrealized gain (loss) on marketable securities | Change in fair value of derivative financial instruments | Total | |||||||||||||
| Balance at December 31, 2020 | $ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||
|
Other comprehensive (loss) income before
reclassifications and income taxes |
(
|
|
|
|
(
|
||||||||||||
|
Amounts reclassified from accumulated other
comprehensive (loss) income before income taxes |
|
(
|
|
|
(
|
||||||||||||
| Income tax benefit (expense) |
|
|
|
(
|
(
|
||||||||||||
|
Net current period other comprehensive
(loss) income, net of income taxes |
(
|
(
|
|
|
(
|
||||||||||||
| Noncontrolling interest |
|
|
|
|
|
||||||||||||
|
Net current period comprehensive (loss) income,
net of income taxes and noncontrolling interest |
(
|
(
|
|
|
(
|
||||||||||||
| Balance at September 30, 2021 | $ |
(
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|||||||
21
Note 16 - Accumulated Other Comprehensive Income (Loss) (continued)
| Foreign currency translation adjustments | Pension and other postretirement liability adjustments | Unrealized gain (loss) on marketable securities | Change in fair value of derivative financial instruments | Total | |||||||||||||
| Balance at June 30, 2020 | $ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
|||||||
|
Other comprehensive income (loss) before
reclassifications and income taxes |
|
(
|
|
(
|
|
||||||||||||
|
Amounts reclassified from accumulated other
comprehensive (loss) income before income taxes |
|
(
|
(
|
(
|
(
|
||||||||||||
| Income tax benefit |
|
|
|
|
|
||||||||||||
|
Net current period other comprehensive
income (loss), net of income taxes |
|
(
|
(
|
(
|
|
||||||||||||
| Noncontrolling interest |
(
|
|
|
|
(
|
||||||||||||
|
Net current period comprehensive income (loss),
net of income taxes and noncontrolling interest |
|
(
|
(
|
(
|
|
||||||||||||
| Balance at September 30, 2020 | $ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
|||||||
| Foreign currency translation adjustments | Pension and other postretirement liability adjustments | Unrealized gain (loss) on marketable securities | Change in fair value of derivative financial instruments | Total | |||||||||||||
| Balance at December 31, 2019 | $ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
|||||||
|
Other comprehensive income before
reclassifications and income taxes |
|
|
|
|
|
||||||||||||
|
Amounts reclassified from accumulated other
comprehensive (loss) income before income taxes |
|
(
|
(
|
(
|
(
|
||||||||||||
| Income tax benefit |
|
|
|
|
|
||||||||||||
|
Net current period other comprehensive income
(loss), net of income taxes |
|
(
|
|
(
|
|
||||||||||||
| Noncontrolling interest |
|
|
|
|
|
||||||||||||
|
Net current period comprehensive income (loss),
net of income taxes and noncontrolling interest |
|
(
|
|
(
|
|
||||||||||||
| Balance at September 30, 2020 | $ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
|||||||
Other comprehensive income (loss) before reclassifications and income taxes includes the effect of foreign currency.
22
Note 17 - Fair Value
Fair value is defined as the price that would be expected to be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (exit price). The FASB provides accounting rules that classify the inputs used to measure fair value into the following hierarchy:
Level 1 – Unadjusted quoted prices in active markets for identical assets or liabilities.
Level 2 – Unadjusted quoted prices in active markets for similar assets or liabilities, or unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or inputs other than quoted prices that are observable for the asset or liability.
Level 3 – Unobservable inputs for the asset or liability.
The following tables present the fair value hierarchy for those financial assets and liabilities measured at fair value on a recurring basis as of September 30, 2021 and December 31, 2020:
| September 30, 2021 | ||||||||||||||
| Total | Level 1 | Level 2 | Level 3 | |||||||||||
| Assets: | ||||||||||||||
| Cash and cash equivalents | $ |
|
$ |
|
$ |
|
$ |
|
||||||
| Restricted cash |
|
|
|
|
||||||||||
| Short-term investments |
|
|
|
|
||||||||||
| Foreign currency forward contracts |
|
|
|
|
||||||||||
| Total Assets | $ |
|
$ |
|
$ |
|
$ |
|
||||||
| Liabilities: | ||||||||||||||
| Foreign currency forward contracts | $ |
|
$ |
|
$ |
|
$ |
|
||||||
| Total Liabilities | $ |
|
$ |
|
$ |
|
$ |
|
||||||
| December 31, 2020 | ||||||||||||||
| Total | Level 1 | Level 2 | Level 3 | |||||||||||
| Assets: | ||||||||||||||
| Cash and cash equivalents | $ |
|
$ |
|
$ |
|
$ |
|
||||||
| Restricted cash |
|
|
|
|
||||||||||
| Short-term investments |
|
|
|
|
||||||||||
| Foreign currency forward contracts |
|
|
|
|
||||||||||
| Total Assets | $ |
|
$ |
|
$ |
|
$ |
|
||||||
| Liabilities: | ||||||||||||||
| Foreign currency forward contracts | $ |
|
$ |
|
$ |
|
$ |
|
||||||
| Total Liabilities | $ |
|
$ |
|
$ |
|
$ |
|
||||||
Cash and cash equivalents are highly liquid investments with maturities of three months or less when purchased and are valued at the redempti
on value. Short-term investments are investments with maturities between four months and one year, and generally are valued at amortized cost, which approximates fair value. A portion of the cash and cash equivalents and short-term investments are valued based on net asset value. The Company uses publicly available foreign currency fo
rward and spot rates to measure the fair value of its foreign currency forward contracts.
In addition, the Company remeasures certain assets at fair value, using Level 3 inputs, as a result of the occurrence of triggering events such as purchase accounting for acquisitions. See
Note 3 - Acquisitions
for further discussion.
No other material assets were measured at fair value on a nonrecurring basis during the nine months ended September 30, 2021 and 2020, respectively.
23
Note 17 - Fair Value (continued)
Financial Instruments:
The Company’s financial instruments consist primarily of cash and cash equivalents, short-term investments, accounts receivable, trade accounts payable, short-term borrowings and long-term debt. Due to their short-term nature, the carrying value of cash and cash equivalents, short-term investments, accounts receivable, trade accounts payable and short-term borrowings are a reasonable estimate of their fair value. Due to the nature of fair value calculati
ons for variable-rate debt, the carrying value of the Company's long-term variable-rate debt is a reasonable estimate of its fair value. The fair value of the Company’s long-term fixed-rate debt, based on quoted market prices, was $
1,193.7
million and $
1,220.7
million at September 30, 2021 and December 31, 2020, respectively. The carrying value of this debt was $
1,091.1
million and $
1,103.2
million at September 30, 2021 and December 31, 2020, respectively. The fair value of long-term fixed-rate debt w
as measured using Level 2 inputs.
The Company does not believe it has significant concentrations of risk associated with the counterparties to its financial instruments.
Note 18 - Derivative Instruments and Hedging Activities
The Company is exposed to certain risks relating to its ongoing business operations. The primary risks managed by using derivative instruments are foreign currency exchange rate risk and interest rate risk. Forward contracts on various foreign currencies are entered into in order to manage the foreign currency exchange rate risk associated with certain of the Company's commitments denominated in foreign currencies. From time to time, interest rate swaps are used to manage interest rate risk associated with the Company’s fixed and floating-rate borrowings.
The Company designates certain foreign currency forward contracts as cash flow hedges of forecasted revenues and certain interest rate hedges as cash flow hedges of fixed-rate borrowings.
On September 8, 2020, the Company entered into a $
100
million floating-to-fixed rate swap on the 2023 Term Loan, which hedges the change in the 1-month LIBOR rate between October 30, 2020 and September 11, 2023 to a fixed rate. The Company’s risk management objective is to hedge the risk of changes in the monthly interest expense attributable to changes in the benchmark interest rate.
On September 15, 2020, the Company designated €
54.5
million of its €
150.0
million fixed-rate senior unsecured notes, maturing on September 7, 2027 (the "2027 Notes"), as a hedge against its net investment in one of its European subsidiaries. The objective of the hedge transaction is to protect the net investment in the foreign operations against changes in the exchange rate between the U.S. dollar and the Euro. The net impact for the three and nine months ended September 30, 2021, respectively, was a gain of $
1.5
million and $
3.5
million to accumulated comprehensive income (loss) with a corresponding offset to o
ther income (expense)
, which partially offsets the impact of the foreign currency adjustment on the 2027 Notes.
The Company does not purchase or hold any derivative financial instruments for trading purposes. As of September 30, 2021 and December 31, 2020, the Company had $
232.0
million a
nd $
173.2
million, respectively, of outstanding foreign currency forward contracts at notional value. Refer to
Note 17 - Fair Value
for the fair value disclosure of derivative financial instruments.
Cash Flow Hedging Strategy:
For certain derivative instruments that are designated and qualify as cash flow hedges (
i.e
., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk), the gain or loss on the derivative instrument is reported as a component of other comprehensive income and reclassified into earnings in the same line item associated with the forecasted transaction and in the same period or periods during which the hedged transaction affects earnings.
24
Note 18 - Derivative Instruments and Hedging Activities (continued)
To protect against a reduction in the value of forecasted foreign currency cash flows resulting from export sales, the Company has instituted a foreign currency cash flow hedging program. The Company hedges portions of its forecasted cash flows denominated in foreign currencies with forward contracts. When the dollar strengthens significantly against foreign currencies, the decline in the present value of future foreign currency revenue is offset by gains in the fair value of the forward contracts designated as hedges. Co
nversely, when the dollar weakens, the increase in the present value of future foreign currency cash flows is offset by losses in the fair value of the forward contracts. As of September 30, 2021 and December 31, 2020, the Company had
$
81.6
million and $
86.9
million,
respectively, of outstanding foreign currency forward contracts at notional value that were classified as cash flow hedges.
The maximum length of time over which the Company hedges its exposure to the variability in future cash flows for forecast transactions is generally eighteen months or less.
Purpose for Derivative Instruments not designated as Hedging Instruments:
For derivative instruments that are not designated as hedging instruments, the instruments are typically forward contracts. In general, the practice is to reduce volatility by selectively hedging transaction exposures including intercompany loans, accounts payable and accounts receivable. Intercompany loans between entities with different functional currencies typically are hedged with a forward contract at the inception of the loan with a maturity date corresponding to the maturity of the loan. The revaluation of these contracts, as well as the revaluation of the underlying balance sheet items, is recorded directly to the income statement so the adjustment generally offsets the revaluation of the underlying balance sheet items to protect cash payments and reduce income statement volatility.
As of September 30, 2021 and December 31, 2020
, the Comp
any had $
150.4
million and $
86.3
million, r
espectively, of outstanding foreign currency forward contracts at notional value that were not designated as hedging instruments.
The following table presents the impact of derivative instruments not designated as hedging instruments for the three and nine months ended September 30, 2021 and 2020, respectively, and the related location within the Consolidated Statements of Income:
| Amount of gain or (loss) recognized in income | ||||||||||||||||||||||||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||||||||||||||
| Derivatives not designated as hedging instruments: | Location of gain or (loss) recognized in income | 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||||
| Foreign currency forward contracts | Other income (expense), net | $ |
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||||
25
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
(Dollars in millions, except per share data)
OVERVIEW
Introduction:
The Timken Company designs and manages a growing portfolio of engineered bearings and power transmission products. With more than a century of innovation and increasing knowledge, the Company continuously improves the reliability and efficiency of global machinery and equipment to move the world forward. The Company’s growing product and services portfolio features many strong industrial brands, such as Timken®, Philadelphia Gear®, Drives®, Cone Drive®, Rollon®, Lovejoy®, Diamond®, BEKA® and Groeneveld®. Timken employs more than
17,000
people globally in
42
countries. The Company operates under two reportable segments: (1) Mobile Industries and (2) Process Industries. The following further describes these business segments:
•
Mobile Industries
serves OEM customers that manufacture off-highway equipment for the agricultural, mining and construction markets; on-highway vehicles including passenger cars, light trucks, and medium- and heavy-duty trucks; rail cars and locomotives; outdoor power equipment; rotorcraft and fixed-wing aircraft; and other mobile equipment. Beyond service parts sold to OEMs, aftermarket sales and services to individual end users, equipment owners, operators and maintenance shops are handled directly or through the Company's extensive network of authorized automotive and heavy-truck distributors.
•
Process Industries
serves OEM and end-user customers in industries that place heavy demands on the fixed operating equipment they make or use in heavy and other general industrial sectors. This includes metals, cement and aggregate production; power generation and renewable energy sources; oil and gas extraction and refining; pulp and paper and food processing; automation and robotics; and health and critical motion control equipment. Other applications include marine equipment, gear drives, cranes, hoists and conveyors. This segment also supports aftermarket sales and service needs through its global network of authorized industrial distributors and through the provision of services directly to end users.
Timken creates value by understanding customer needs and applying its know-how to serve a broad range of customers in attractive markets and industries across the globe. The Company’s business strengths include its product technology, end-market diversity, geographic reach and aftermarket mix. Timken collaborates with OEMs to improve equipment efficiency with its engineered products and captures subsequent equipment replacement cycles by selling largely through independent channels in the aftermarket. Timken focuses its international efforts and footprint in regions of the world where strong macroeconomic factors such as urbanization, infrastructure development and sustainability create demand for its products and services.
The Company's strategy has three primary elements:
Profitable Growth.
The Company intends to expand into new and existing markets by leveraging its collective knowledge of metallurgy, friction management and power transmission to create value for Timken customers. Using a highly collaborative technical selling approach, the Company places particular emphasis on creating unique solutions for challenging and/or demanding applications. The Company intends to grow in attractive market sectors around the world, emphasizing those spaces that are highly fragmented, demand high service and value the reliability and efficiency offered by Timken products. The Company also targets applications that offer significant aftermarket demand, thereby providing product and services revenue throughout the equipment’s lifetime.
Operating With Excellence.
Timken operates with a relentless drive for exceptional results and a passion for superior execution. The Company embraces a continuous improvement culture that is charged with increasing efficiency, lowering costs, eliminating waste, encouraging organizational agility and building greater brand equity to fuel growth. This requires the Company’s ongoing commitment to attract, retain and develop the best talent across the world.
26
Capital Deployment to Drive Shareholder Value.
The Company is intently focused on providing the highest returns for shareholders through its capital allocation framework, which includes: (1) investing in the core business through capital expenditures, research and development and initiatives to drive profitable organic growth; (2) pursuing strategic acquisitions to broaden its portfolio and capabilities across diverse markets, with a focus on bearings, adjacent power transmission products and related services; (3) returning capital to shareholders through dividends and share repurchases; and (4) maintaining a strong balance sheet and sufficient liquidity. As part of this framework, the Company may also restructure, reposition or divest underperforming product lines or assets.
Overview:
|
Three Months Ended
September 30, |
||||||||||||||
| 2021 | 2020 | $ Change | % Change | |||||||||||
| Net sales | $ | 1,037.3 | $ | 894.6 | $ | 142.7 | 16.0 | % | ||||||
| Net income | 91.6 | 91.3 | 0.3 | 0.3 | % | |||||||||
| Net income attributable to noncontrolling interest | 3.5 | 2.5 | 1.0 | 40.0 | % | |||||||||
| Net income attributable to The Timken Company | $ | 88.1 | $ | 88.8 | $ | (0.7) | (0.8) | % | ||||||
| Diluted earnings per share | $ | 1.14 | $ | 1.16 | $ | (0.02) | (1.7) | % | ||||||
| Average number of shares – diluted | 77,023,973 | 76,286,136 | — | 1.0 | % | |||||||||
|
Nine Months Ended
September 30, |
||||||||||||||
| 2021 | 2020 | $ Change | % Change | |||||||||||
| Net sales | $ | 3,125.6 | $ | 2,621.5 | $ | 504.1 | 19.2 | % | ||||||
| Net income | 314.8 | 237.1 | 77.7 | 32.8 | % | |||||||||
| Net income attributable to noncontrolling interest | 8.6 | 5.7 | 2.9 | 50.9 | % | |||||||||
| Net income attributable to The Timken Company | $ | 306.2 | $ | 231.4 | $ | 74.8 | 32.3 | % | ||||||
| Diluted earnings per share | $ | 3.97 | $ | 3.04 | $ | 0.93 | 30.6 | % | ||||||
| Average number of shares – diluted | 77,157,614 | 76,131,920 | — | 1.3 | % | |||||||||
The increase in net sales for the three months ended September 30, 2021 compared with the three months ended September 30, 2020 was primarily driven by higher organic sales volume across most market sectors, positive pricing, the favorable impact of foreign currency exchange rate changes and the benefit of acquisitions. The decrease in net income for the three months ended September 30, 2021 compared with the three months ended September 30, 2020 was primarily due to higher material, logistics and other operating costs and higher pension remeasurement losses, mostly offset by the favorable impact of higher volume and related manufacturing utilization, lower restructuring charges, positive price/mix and a lower tax rate. In addition, the impact of foreign currency exchange rate changes was favorable versus the year-ago period.
The increase in net sales for the nine months ended September 30, 2021 compared with the nine months ended September 30, 2020 was primarily driven by higher organic revenue across most market sectors, as well as the favorable impact of foreign currency exchange rate changes and the benefit of acquisitions. The increase in net income for the nine months ended September 30, 2021 compared with the nine months ended September 30, 2020 was primarily due to the favorable impact of higher volume and related manufacturing utilization, lower restructuring charges and a lower tax rate, partially offset by higher material, logistics and other operating costs, unfavorable price/mix and higher pension remeasurement losses. In addition, the impact of foreign currency exchange rate changes was favorable versus the year-ago period.
27
Outlook:
The world continues to be impacted by the COVID-19 pandemic. Timken has implemented plans across the enterprise to operate in a safe manner, while protecting employees and adhering to mandates and other guidance from local governments and health authorities. The Company’s main priority continues to be the health of its employees and others in the communities where it does business.
With pandemic conditions generally improving across the globe, industrial markets have strengthened in most sectors, and the Company has experienced supply chain disruptions, inflation and staffing issues related to serving the increased customer demand. For the first nine months of 2021, Timken has been able to serve customers and meet demand levels across most markets, although at higher costs than previously anticipated. Timken’s outlook assumes that COVID-19 conditions will continue to improve, but that supply chain disruptions and inflationary pressures will persist into 2022.
Given the continued uncertainty surrounding supply chain disruptions and the COVID-19 pandemic, the Company is not providing detailed sales and earnings guidance at this time. However, the Company expects 2021 full-year revenue to be up compared to 2020, primarily due to higher sales volume across most market sectors, as well as the impact of positive pricing, foreign currency exchange rate changes and acquisitions. The Company's earnings are expected to be up in 2021 compared with 2020, primarily due to the impact of higher volume and related manufacturing utilization, the favorable impact of foreign currency exchange rate changes, lower restructuring expenses and a lower tax rate, partially offset by higher material, logistics and other operating costs.
Timken expects to generate solid cash from operating activities in 2021, although down from the $577.6 million in 2020, as the impact of higher earnings is expected to be more than offset by unfavorable changes in working capital (i.e., a use of cash in 2021 versus a source of cash in 2020) to support the higher sales levels. The Company expects capital expenditures to be approximately $150 million in 2021, compared with $122 million in 2020.
28
THE STATEMENT OF INCOME
Sales:
|
Three Months Ended
September 30, |
||||||||||||||
| 2021 | 2020 | $ Change | % Change | |||||||||||
| Net Sales | $ | 1,037.3 | $ | 894.6 | $ | 142.7 | 16.0 | % | ||||||
|
Nine Months Ended
September 30, |
||||||||||||||
| 2021 | 2020 | $ Change | % Change | |||||||||||
| Net Sales | $ | 3,125.6 | $ | 2,621.5 | $ | 504.1 | 19.2 | % | ||||||
Net sales increased for the three months ended September 30, 2021 compared with the three months ended September 30, 2020. The increase was primarily due to higher organic revenue of $118 million, the favorable impact of foreign currency exchange rate changes of $17 million and the benefit of acquisitions of $8 million. The higher organic revenue was driven by higher demand across both the Mobile Industries and Process Industries segments.
Net sales increased for the nine months ended September 30, 2021 compared with the nine months ended September 30, 2020. The increase was primarily due to higher organic revenue of $400 million, the favorable impact of foreign currency exchange rate changes of $81 million and the benefit of the acquisitions of $24 million. The higher organic revenue was driven by higher demand across both the Mobile Industries and Process Industries segments.
Gross Profit:
|
Three Months Ended
September 30, |
||||||||||||||
| 2021 | 2020 | $ Change | Change | |||||||||||
| Gross profit | $ | 267.9 | $ | 263.7 | $ | 4.2 | 1.6% | |||||||
| Gross profit % to net sales | 25.8 | % | 29.5 | % | (370) | bps | ||||||||
|
Nine Months Ended
September 30, |
||||||||||||||
| 2021 | 2020 | $ Change | Change | |||||||||||
| Gross profit | $ | 869.4 | $ | 772.9 | $ | 96.5 | 12.5% | |||||||
| Gross profit % to net sales | 27.8 | % | 29.5 | % | (170) | bps | ||||||||
Gross profit increased for the three months ended September 30, 2021 compared with the three months ended September 30, 2020, primarily due to the impact of higher volume of $42 million, favorable net manufacturing performance of $5 million, favorable price/mix of $6 million, and the favorable impact of foreign currency exchange rate changes of $6 million, partially offset by higher materials and logistics costs of $53 million.
Gross profit increased for the nine months ended September 30, 2021 compared with the nine months ended September 30, 2020, primarily due to the impact of higher volume of $156 million, favorable net manufacturing performance of $28 million, the favorable impact of foreign currency exchange rate changes of $23 million, and the favorable impact of acquisitions of $7 million. These increases were partially offset by higher materials and logistics costs of $110 million and unfavorable price/mix of $10 million.
29
Selling, General and Administrative Expenses:
|
Three Months Ended
September 30, |
||||||||||||||
| 2021 | 2020 | $ Change | Change | |||||||||||
| Selling, general and administrative expenses | $ | 140.7 | $ | 132.7 | $ | 8.0 | 6.0 | % | ||||||
| Selling, general and administrative expenses % to net sales | 13.6 | % | 14.8 | % | (120) | bps | ||||||||
|
Nine Months Ended
September 30, |
||||||||||||||
| 2021 | 2020 | $ Change | Change | |||||||||||
| Selling, general and administrative expenses | $ | 434.2 | $ | 398.1 | $ | 36.1 | 9.1 | % | ||||||
| Selling, general and administrative expenses % to net sales | 13.9 | % | 15.2 | % | (130) | bps | ||||||||
SG&A expenses increased in the three and nine months ended September 30, 2021 compared with the three and nine months ended September 30, 2020. The increase for the three months ended September 30, 2021, as compared to the year-ago period, was primarily due to higher spending to support the higher sales levels, partially offset by lower incentive compensation expense. The increase for the nine months ended September 30, 2021, as compared to the year-ago period, was primarily due to the favorable impact of 2020 cost reduction initiatives, including temporary salary reductions and work furloughs implemented during the nine months ended September 30, 2020 in response to the COVID-19 pandemic, which did not repeat in the current year.
Impairment and Restructuring:
|
Three Months Ended
September 30, |
||||||||||||||
| 2021 | 2020 | $ Change | % Change | |||||||||||
| Severance and related benefit costs | $ | 2.5 | $ | 11.9 | $ | (9.4) | (79.0) | % | ||||||
| Exit costs | 0.4 | 0.1 | 0.3 | 300.0 | % | |||||||||
| Total | $ | 2.9 | $ | 12.0 | $ | (9.1) | (75.8) | % | ||||||
|
Nine Months Ended
September 30, |
||||||||||||||
| 2021 | 2020 | $ Change | % Change | |||||||||||
| Impairment charges | $ | 4.5 | $ | 0.1 | $ | 4.4 | NM | |||||||
| Severance and related benefit costs | 3.1 | 17.8 | (14.7) | (82.6) | % | |||||||||
| Exit costs | 0.6 | 0.8 | (0.2) | (25.0) | % | |||||||||
| Total | $ | 8.2 | $ | 18.7 | $ | (10.5) | (56.1) | % | ||||||
Impairment and restructuring charges of $2.9 million and $8.2 million during the three and nine months ended September 30, 2021 were comprised primarily of severance and related benefits related to the planned closures of the Company's Villa Carcina, Italy bearing plant and Indianapolis, Indiana chain plant. These initiatives are expected to reduce headcount and right-size the Company's manufacturing footprint. In addition, impairment and restructuring during the nine months ended September 30, 2021 included impairment charges related to certain engineering-related assets used in the business. Management concluded no further investment would be made in the engineered-related assets and, as a result, reduced the value to zero.
Impairment and restructuring charges of $12.0 million and $18.7 million during the three and nine months ended September 30, 2020 were comprised primarily of severance and related benefits associated with initiatives to reduce headcount and right-size the Company's manufacturing footprint, including planned closure of the Company's Indianapolis, Indiana chain plant and the reorganization of the Company's Canton, Ohio and Gaffney, South Carolina bearing facilities.
Refer to
Note 13 - Impairment and Restructuring Charges
in
the Notes to the Consolidated Financial Statements for additional information.
30
Other Income (Expense):
|
Three Months Ended
September 30, |
||||||||||||||
| 2021 | 2020 | $ Change | % Change | |||||||||||
| Non-service pension and other postretirement income | $ | 0.5 | $ | 15.3 | $ | (14.8) | (96.7) | % | ||||||
| Other income (expense), net | 1.5 | (1.0) | 2.5 | (250.0) | % | |||||||||
| Total other income | $ | 2.0 | $ | 14.3 | $ | (12.3) | (86.0) | % | ||||||
|
Nine Months Ended
September 30, |
||||||||||||||
| 2021 | 2020 | $ Change | % Change | |||||||||||
| Non-service pension and other postretirement income | $ | 5.9 | $ | 13.4 | $ | (7.5) | (56.0) | % | ||||||
| Other income | 0.3 | 1.1 | (0.8) | (72.7) | % | |||||||||
| Total other income | $ | 6.2 | $ | 14.5 | $ | (8.3) | (57.2) | % | ||||||
Non-service pension and other postretirement income decreased for the three and nine months ended September 30, 2021 compared with the three and nine months ended September 30, 2020, primarily due to the recognition of pension remeasurement losses in 2021, compared to pension remeasurement gains in 2020. The remeasurements were triggered by lump sum payments to new retirees exceeding annual service and interest costs for three of the Company's U.S. defined benefit pension plans. As a result of the remeasurements, the Company recognized net actuarial losses of $3.9 million and $8.3 million during the three and nine months ended September 30, 2021, respectively.
The actuarial gains in three and nine months ended September 30, 2020 were due to the remeasurement of pension plan assets and obligations, as well as the Company's announcement of the reorganization of one of its bearing plants in Canton, Ohio. The remeasurements were triggered as a result of lump sum payments to new retirees in 2020 that exceeded annual service and interest costs, and the reorganization triggered a curtailment of one of the Company's U.S. defined benefit pension plans. As a result of the remeasurement and curtailment, the Company recognized net actuarial gains of $11.9 million and $3.1 million during the three and nine months ended September 30, 2020, respectively. Refer to
Note 14 - Retirement Benefit Plans
and
Note 15 - Other Postretirement Benefit Plans
in
the Notes to the Consolidated Financial Statements for additional information.
Other income (expense), net increased for the three months ended September 30, 2021 compared with the three months ended September 30, 2020, primarily due to lower foreign currency exchange losses. Other income decreased for the nine months ended September 30, 2021 compared with the nine months ended September 30, 2020, primarily due to lower insurance recoveries.
31
Income Tax Expense:
|
Three Months Ended
September 30, |
||||||||||||||
| 2021 | 2020 | $ Change | % Change | |||||||||||
| Provision for income taxes | $ | 20.4 | $ | 26.6 | $ | (6.2) | (23.3) | % | ||||||
| Effective tax rate | 18.2 | % | 22.6 | % | (440) | bps | ||||||||
|
Nine Months Ended
September 30, |
||||||||||||||
| 2021 | 2020 | $ Change | % Change | |||||||||||
| Provision for income taxes | $ | 75.1 | $ | 84.2 | $ | (9.1) | (10.8) | % | ||||||
| Effective tax rate | 19.3 | % | 26.2 | % | (690) | bps | ||||||||
Income tax expense decreased $6.2 million for the three months ended September 30, 2021 compared with the three months ended September 30, 2020, primarily due to the release of accruals for uncertain tax positions and favorable U.S. permanent book-tax differences, including the new elective GILTI high tax exemption rules. The impact was partially offset by the mix of earnings in higher tax rate jurisdictions.
Income tax expense decreased $9.1 million for the nine months ended September 30, 2021 compared with the nine months ended September 30, 2020, primarily due to the release of accruals for uncertain tax positions and favorable U.S. permanent book-tax differences, including the tax impact from stock-based compensation awards and the new elective GILTI high tax exemption rules. This impact was partially offset by increased income taxes due to higher pre-tax earnings that increased the mix of earnings in higher tax rate jurisdictions.
Refer to
Note 6 - Income Taxes
for more information on the computation of the income tax expense in interim periods.
BUSINESS SEGMENTS
The Company
'
s reportable segments are business units that serve different industry sectors. While the segments operate using shared infrastructure, each reportable segment is managed to address specific customer needs in these diverse market sectors. The primary measurement used by management to measure the financial performance of each segment is EBITDA. Refer to
Note 5 - Segment Information
in the Notes to the Consolidated Financial Statements for the reconciliation of EBITDA by segment to consolidated income before income taxes.
The presentation of segment results below includes a reconciliation of the changes in net sales for each segment reported in accordance with U.S. GAAP to net sales adjusted to remove the effects of acquisitions completed in 2021
and
2020 and foreign currency exchange rate changes. The effects of acquisitions and foreign currency exchange rate changes on net sales are removed to allow investors and the Company to meaningfully evaluate the percentage change in net sales on a comparable basis from period to period.
The following items highlight the Company's acquisitions completed in 2021 and 2020:
•
The Company acquired iMS during the third quarter of 2
021. The majority of the results for iMS are reported in the Process Industries segment.
•
The Company acquired Aurora during the fourth quarter of 2020. Results for Aurora are reported in the Mobile Industries and Process Industries segments based on customers and underlying market sectors served.
32
Mobile Industries Segment:
|
Three Months Ended
September 30, |
||||||||||||||
| 2021 | 2020 | $ Change | Change | |||||||||||
| Net sales | $ | 487.3 | $ | 428.6 | $ | 58.7 | 13.7% | |||||||
| EBITDA | $ | 53.2 | $ | 64.0 | $ | (10.8) | (16.9%) | |||||||
| EBITDA margin | 10.9 | % | 14.9 | % | (400) | bps | ||||||||
|
Three Months Ended
September 30, |
||||||||||||||
| 2021 | 2020 | $ Change | % Change | |||||||||||
| Net sales | $ | 487.3 | $ | 428.6 | $ | 58.7 | 13.7 | % | ||||||
| Less: Acquisitions | 3.9 | — | 3.9 | NM | ||||||||||
| Currency | 4.6 | — | 4.6 | NM | ||||||||||
| Net sales, excluding the impact of acquisitions and currency | $ | 478.8 | $ | 428.6 | $ | 50.2 | 11.7 | % | ||||||
|
Nine Months Ended
September 30, |
||||||||||||||
| 2021 | 2020 | $ Change | Change | |||||||||||
| Net sales | $ | 1,486.0 | $ | 1,237.9 | $ | 248.1 | 20.0% | |||||||
| EBITDA | $ | 200.1 | $ | 177.9 | $ | 22.2 | 12.5% | |||||||
| EBITDA margin | 13.5 | % | 14.4 | % | (90) | bps | ||||||||
|
Nine Months Ended
September 30, |
||||||||||||||
| 2021 | 2020 | $ Change | % Change | |||||||||||
| Net sales | $ | 1,486.0 | $ | 1,237.9 | $ | 248.1 | 20.0 | % | ||||||
| Less: Acquisitions | 12.7 | — | 12.7 | NM | ||||||||||
| Currency | 26.4 | — | 26.4 | NM | ||||||||||
| Net sales, excluding the impact of acquisitions and currency | $ | 1,446.9 | $ | 1,194.4 | $ | 209.0 | 17.5 | % | ||||||
The Mobile Industries segment's net sales, excluding the effects of acquisitions and foreign currency exchange rate changes, increased $50.2 million or 11.7% in the three months ended September 30, 2021 compared with the three months ended September 30, 2020, reflecting increased shipments in the off-highway and heavy truck sectors, as well as positive pricing, partially offset by lower shipments in the automotive and rail sectors. EBITDA decreased by $10.8 million or 16.9% in the three months ended September 30, 2021 compared with the three months ended September 30, 2020, primarily due to higher material, logistics and other operating costs, partially offset by the impact of higher volume and related manufacturing utilization.
The Mobile Industries segment's net sales, excluding the effects of acquisitions and foreign currency exchange rate changes, increased $209.0 million or 17.5% in the nine months ended September 30, 2021 compared with the nine months ended September 30, 2020, reflecting organic growth in the off-highway, automotive and heavy truck sectors. These increases were partially offset by lower shipments in the aerospace and rail sectors. EBITDA increased by $22.2 million or 12.5% in the nine months ended September 30, 2021 compared with the nine months ended September 30, 2020, primarily due to the impact of higher volume and related manufacturing utilization, partially offset by higher material, logistics and other operating costs.
33
Process Industries Segment:
|
Three Months Ended
September 30, |
||||||||||||||
| 2021 | 2020 | $ Change | Change | |||||||||||
| Net sales | $ | 550.0 | $ | 466.0 | $ | 84.0 | 18.0% | |||||||
| EBITDA | $ | 129.7 | $ | 109.2 | $ | 20.5 | 18.8% | |||||||
| EBITDA margin | 23.6 | % | 23.4 | % | 20 | bps | ||||||||
|
Three Months Ended
September 30, |
||||||||||||||
| 2021 | 2020 | $ Change | % Change | |||||||||||
| Net sales | $ | 550.0 | $ | 466.0 | $ | 84.0 | 18.0 | % | ||||||
| Less: Acquisitions | 3.8 | — | 3.8 | NM | ||||||||||
| Currency | 12.0 | — | 12.0 | NM | ||||||||||
| Net sales, excluding the impact of acquisitions and currency | $ | 534.2 | $ | 466.0 | $ | 68.2 | 14.6 | % | ||||||
|
Nine Months Ended
September 30, |
||||||||||||||
| 2021 | 2020 | $ Change | Change | |||||||||||
| Net sales | $ | 1,639.6 | $ | 1,383.6 | $ | 256.0 | 18.5% | |||||||
| EBITDA | $ | 401.9 | $ | 343.0 | $ | 58.9 | 17.2% | |||||||
| EBITDA margin | 24.5 | % | 24.8 | % | (30) | bps | ||||||||
|
Nine Months Ended
September 30, |
||||||||||||||
| 2021 | 2020 | $ Change | % Change | |||||||||||
| Net sales | $ | 1,639.6 | $ | 1,383.6 | $ | 256.0 | 18.5 | % | ||||||
| Less: Acquisitions | 11.0 | — | 11.0 | NM | ||||||||||
| Currency | 54.1 | — | 54.1 | NM | ||||||||||
| Net sales, excluding the impact of acquisitions and currency | $ | 1,574.5 | $ | 1,363.8 | $ | 210.7 | 15.4 | % | ||||||
The Process Industries segment's net sales, excluding the effects of acquisitions and foreign currency exchange rate changes, increased $68.2 million or 14.6% in the three months ended September 30, 2021 compared with the three months ended September 30, 2020. The increase was primarily driven by increased demand in the distribution, general industrial, renewable energy, and heavy industries sectors, as well as positive pricing. EBITDA increased $20.5 million or 18.8% in the three months ended September 30, 2021 compared with the three months ended September 30, 2020 primarily due to higher volume and related manufacturing utilization and the favorable impact of foreign currency exchange rate changes, partially offset by higher material and logistics costs.
The Process Industries segment's net sales, excluding the effects of acquisitions and foreign currency exchange rate changes, increased $210.7 million or 15.4% in the nine months ended September 30, 2021 compared with the nine months ended September 30, 2020. The increase was primarily driven by increased demand in the distribution, renewable energy and general industrial sectors. EBITDA increased $58.9 million or 17.2% in the nine months ended September 30, 2021 compared with the nine months ended September 30, 2020 primarily due to higher volume and related manufacturing utilization, and the favorable impact of foreign currency exchange rate changes, partially offset by higher material, logistics and other operating costs, as well as unfavorable mix.
34
Unallocated Corporate:
|
Three Months Ended
September 30, |
||||||||||||||
| 2021 | 2020 | $ Change | Change | |||||||||||
| Unallocated corporate expense | $ | (11.7) | $ | (10.6) | $ | (1.1) | 10.4 | % | ||||||
| Unallocated corporate expense % to net sales | (1.1) | % | (1.2) | % | 10 | bps | ||||||||
|
Nine Months Ended
September 30, |
||||||||||||||
| 2021 | 2020 | $ Change | Change | |||||||||||
| Unallocated corporate expense | $ | (34.9) | $ | (28.2) | $ | (6.7) | 23.8 | % | ||||||
| Unallocated corporate expense % to net sales | (1.1) | % | (1.1) | % | — | bps | ||||||||
The increase in unallocated corporate expense for the
nine
months ended September 30, 2021 compared with the
nine
months ended September 30, 2020, was primarily due to the favorable impact of COVID-19 related temporary cost reduction initiatives in 2020, which did not repeat in 2021.
35
CASH FLOW
|
Nine Months Ended
September 30, |
|||||||||||
| 2021 | 2020 | $ Change | |||||||||
| Net cash provided by operating activities | $ | 284.6 | $ | 457.2 | $ | (172.6) | |||||
| Net cash used in investing activities | (115.9) | (101.4) | (14.5) | ||||||||
| Net cash used in financing activities | (222.4) | (257.7) | 35.3 | ||||||||
| Effect of exchange rate changes on cash | (4.8) | (0.3) | (4.5) | ||||||||
| (Decrease) increase in cash, cash equivalents and restricted cash | $ | (58.5) | $ | 97.8 | $ | (156.3) | |||||
Op
erating Activities:
The decrease in net cash provided by operating activities for the first nine months of 2021 compared with the first nine months of 2020 was primarily due to an increase in cash used for working capital items of $196.5 million, a reduction in the benefit of income taxes on cash of $12.4 million, an increase in pension and other postretirement benefit contributions and payments of $5.3 million and a decrease in other items. The decrease was partially offset by higher net income of $77.7 million. Refer to the tables below for additional detail of the impact of each line item on net cash provided by operating activities.
The following table displays the impact of working capital items on cash during the nine months of 2021 and 2020, respectively:
|
Nine Months Ended
September 30, |
|||||||||||
| 2021 | 2020 | $ Change | |||||||||
| Cash (Used) Provided: | |||||||||||
| Accounts receivable | $ | (127.5) | $ | (27.6) | $ | (99.9) | |||||
| Unbilled receivables | 25.1 | (11.9) | 37.0 | ||||||||
| Inventories | (144.2) | 47.9 | (192.1) | ||||||||
| Trade accounts payable | 60.5 | 2.8 | 57.7 | ||||||||
| Other accrued expenses | 50.2 | 49.4 | 0.8 | ||||||||
| Cash (used in) provided by working capital items | $ | (135.9) | $ | 60.6 | $ | (196.5) | |||||
The following table displays the impact of income taxes on cash during the nine months of 2021 and 2020, respectively:
|
Nine Months Ended
September 30, |
|||||||||||
| 2021 | 2020 | $ Change | |||||||||
| Accrued income tax expense | $ | 75.1 | $ | 84.2 | $ | (9.1) | |||||
| Income tax payments | (80.0) | (78.6) | (1.4) | ||||||||
| Other miscellaneous items | (1.8) | 0.1 | (1.9) | ||||||||
| Cash (expense) benefit from income taxes | $ | (6.7) | $ | 5.7 | $ | (12.4) | |||||
Investing Activities:
The increase in net cash used in investing activities for the first nine months of 2021 compared with the first nine months of 2020 was primarily due to an increase in capital expenditures of $17.9 million.
Financing Activities:
The change in net cash used in financing activities decreased for the first nine months of 2021 compared with the first nine months of 2020, primarily due to a decrease in net payments of $41.5 million on outstanding debt, as well as lower dividends of $15.3 million to noncontrolling interest parties. These changes were partially offset by an increase in the purchase of treasury shares of $14.3 million.
36
LIQUIDITY AND CAPITAL RESOURCES
Reconciliation of total debt to net debt and the ratio of net debt to capital:
Net Debt:
|
September 30,
2021 |
December 31,
2020 |
|||||||
| Short-term debt | $ | 27.9 | $ | 119.8 | ||||
| Current portion of long-term debt | 11.1 | 10.9 | ||||||
| Long-term debt | 1,417.0 | 1,433.9 | ||||||
| Total debt | $ | 1,456.0 | $ | 1,564.6 | ||||
| Less: Cash and cash equivalents | 261.8 | 320.3 | ||||||
| Net debt | $ | 1,194.2 | $ | 1,244.3 | ||||
Ratio of Net Debt to Capital:
|
September 30,
2021 |
December 31,
2020 |
|||||||
| Net debt | $ | 1,194.2 | $ | 1,244.3 | ||||
| Total equity | 2,376.4 | 2,225.2 | ||||||
| Net debt plus total equity (capital) | $ | 3,570.6 | $ | 3,469.5 | ||||
| Ratio of net debt to capital | 33.4 | % | 35.9 | % | ||||
The Company presents net debt because it believes net debt is more representative of the Company's financial position than total debt due to the amount of cash and cash equivalents held by the Company and the ability to utilize such cash and cash equivalents to reduce debt if needed.
At September 30, 2021, the Co
mpany had strong liquidity with $261.8 million of cash and cash equivalents on the Consolidated Balance Sheet. Cash and cash equivalents of $244.4 million of the total cash and cash equivalents of $261.8 million resides in jurisdictions outside the United States. Repatriation of non-U.S. cash could be subject to taxes and some portion may be subject to governmental restrictions. Part of the Company's strategy is to grow in attractive market sectors, many of which are outside the United States. This strategy includes making investments in facilities, equipment and potential new acquisitions. The Company plans to fund these investments, as well as meet working capital requirements, with cash and cash equivalents and unused lines of credit within the geographic location of these investments where feasible.
On June 25, 2019, the Company entered into the Senior Credit Facility, which is a $650.0 million unsecured revolving credit facility that matures on June 25, 2024. At September 30, 2021, the Senior Credit Facility had outstanding borrowings of $9.2 million, which reduced the availability to $640.8 million. The Senior Credit Facility has two financial covenants: a consolidated leverage ratio and a consolidated interest coverage ratio. The maximum consolidated
leverage ratio permitted under the Senior Credit Facility is 3.5 to 1.0. As of September 30, 2021, the Company's consolidated leverage ratio was 2.0 to 1.0 (based on total debt as described below). The minimum consolidated interest coverage ratio permitted under the Senior Credit Facility is 3.0 to 1.0. As of September 30, 2021, the Company's consolidated interest coverage ratio was 12.4 to 1.0.
On May 27, 2020, both the Senior Credit Facility and the 2023 Term Loan were amended to, among other things, effectively increase the limit with respect to the consolidated leverage ratio. As amended, the consolidated leverage ratio under both the Senior Credit Facility and the 2023 Term Loan was calculated using a net debt construct, netting unrestricted cash in excess of $25 million, instead of total debt. This change to the consolidated leverage ratio calculation was effective through June 30, 2021. In the third quarter of 2021, the calculation of the consolidated leverage ratio under the Senior Credit Facility and the 2023 Term Loan reverted back to a total debt construct.
37
The interest rate under the Senior Credit Facility is variable with a spread based on the Company's debt rating. The average rate on outstanding U.S. dollar borrowings was 1.12% and the average rate on outstanding Euro borrowings was 1.05% as of September 30, 2021. In addition, the Company pays a facility fee based on the applicable rate, which is variable with a spread based on the Company's debt rating, multiplied by the aggregate commitments of all of the lenders under the Senior Credit Facility. As of September 30, 2021, the Company carried investment-grade credit ratings with Moody's (Baa2), S&P Global (BBB-) and Fitch (BBB-).
The Company has a $100 million Accounts Receivable Facility, which matures on November 30, 2021. The Accounts Receivable Facility is subject to
certain borrowing base limitations and is secured by certain domestic trade accounts receivable of the Company. Borrowings under the Accounts Receivable Facility were not reduced by any such borrowing base limitations at September 30, 2021. As of September 30, 2021, the Company had no outstanding borrowings under the Accounts Receivable Facility.
The Company intends to replace the Accounts Receivable Facility prior to its maturity.
Other sources of liquidity include uncommitted short-term lines of credit for certain of the Company's foreign subsidiaries, which provide for borrowings of up to approximately $287.4 million. At September 30, 2021, the Company had borrowings outstanding of $27.9 million and bank guarantees of $0.5 million, which reduced the aggregate availability under these facilities to approximately $259.0 million.
At September 30, 2021, the Company was in full compliance with all applicable covenants on its outstanding debt, and expects to remain in full compliance with its debt covenants.
The Company expects to generate solid cash from operating activities in 2021, although down from the $577.6 million in 2020, as the impact of higher earnings is expected to be more than offset by unfavorable changes in working capital (i.e., a use of cash in 2021 versus a source of cash in 2020) to support the higher sales levels. The Company expects capital expenditures to be approximately $150 million in 2021, compared with $122 million in 2020.
Financing Obligations and Other Commitments:
During the first nine months of 2021, the Company made cash contributions and payments of
$15.2 million
to its global defined benefit pension plans and
$3.0 million
to its other postretirement benefit plans. The Company expects to make contributions to its global defined benefit plans of appr
oximately $17 million in 2021. The Company expects to make payments of approximately $5 million to its other postretirement benefit plans in 2021. Excluding mark-to-market charges, the Company expects lower pension and other post
retirement benefits expense in 2021.
The Company does not have any off-balance sheet arrangements with unconsolidated entities or other persons.
CRITICAL ACCOUNTING POLICIES AND ESTIMATES
The Company's financial statements are prepared in accordance with U.S. GAAP. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the periods presented. The Company reviews its critical accounting policies throughout the year. The Company has concluded that there have been no significant changes to its critical accounting policies or estimates, as described in its Annual Report on Form 10-K for the year ended December 31, 2020, during the nine months ended September 30, 2021.
38
OTHER MATTERS
Foreign Currency:
Assets and liabilities of subsidiaries are translated at the rate of exchange in effect on the balance sheet date; income and expenses are translated at the average rates of exchange prevailing during the reporting period. Related translation adjustments are reflected as a separate component of accumulated other comprehensive loss. Foreign currency gains and losses resulting from transactions, and the related hedging activity, are included in the Consolidated Statements of Income.
For the nine months ended September 30, 2021, th
e Company recorded negative foreign currency translation adjustments of $53.3 million that decreased
shareholders' equity, compared wit
h positive foreign currency translation adjustments of $15.0 million that increased sh
areholders' equity for the nine months ended September 30, 2020. The foreign currency translation adjustments for the nine months ended September 30, 2021 w
ere negatively impacted by the strengthening
of the U.S. dollar relative to other foreign currencies, including th
e Euro.
Foreign currency exchange gains and losses, net of hedging activity, resulting from transactions included in the Company's operating results for the three months ended September 30, 2021 totale
d $3.2 million of net losses,
compared with
$4.6 million of net losses durin
g the three months ended September 30, 2020. Foreign currency exchange gains and losses, net of hedging activity, resulting from transactions included in the Company's operating results for the nine months ended September 30, 2021 totale
d $8.8 million of net losses, c
ompared
with $3.9 million of net losses
during the nine months ended September 30, 2020.
NON-GAAP MEASURES
Supplemental Non-GAAP Measures:
In addition to results reported in accordance with U.S. GAAP, the Company provides information on non-GAAP financial measures. These non-GAAP financial measures include adjusted net income, adjusted earnings per share, adjusted EBITDA and adjusted EBITDA margins, segment adjusted EBITDA and segment adjusted EBITDA margins, ratio of net debt to adjusted EBITDA (for the trailing 12 months), net debt, ratio of net debt to capital and free cash flow. This information is intended to supplement GAAP financial measures and is not intended to replace GAAP financial measures. Net debt and the ratio of net debt to capital is disclosed in the "Liquidity and Capital Resources" section of Management's Discussion and Analysis of Financial Condition and Results of Operations.
Adjusted Net Income and Adjusted EBITDA:
Adjusted net income and adjusted earnings per share represent net income attributable to The Timken Company and diluted earnings per share, respectively, adjusted for impairment, restructuring and reorganization charges, acquisition costs, including transaction costs and the amortization of the inventory step-up, property losses and recoveries, actuarial gains and losses associated with the remeasurement of the Company's defined benefit pension and other postretirement benefit plans, gains and losses on the sale of real estate, gains and losses on divestitures, the income tax impact of these adjustments, as well as other income tax discrete items, and other items from time to time that are not part of the Company's core operations. Management believes adjusted net income and adjusted earnings per share are useful to investors as they are representative of the Company's core operations and are used in the management of the business, including decisions concerning the allocation of resources and assessment of performance.
Adjusted EBITDA represents earnings before interest, taxes, depreciation and amortization, adjusted for items that are not part of the Company's core operations. These items include impairment, restructuring and reorganization charges, acquisition costs, including transaction costs and the amortization of the inventory step-up, property losses and recoveries, actuarial gains and losses associated with the remeasurement of the Company's defined benefit pension and other postretirement benefit plans, gains and losses on the sale of real estate, gains and losses on divestitures, and other items from time to time that are not part of the Company's core operations. Management believes adjusted EBITDA is useful to investors as it is representative of the Company's core operations and is used in the management of the business, including decisions concerning the allocation of resources and assessment of performance.
39
Reconciliation of net income attributable to The Timken Company to adjusted net income, adjusted EBITDA and adjusted EBITDA Margin:
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||
| 2021 | 2020 | 2021 | 2020 | |||||||||||
| Net Sales | $ | 1,037.3 | $ | 894.6 | $ | 3,125.6 | $ | 2,621.5 | ||||||
| Net Income Attributable to The Timken Company | 88.1 | 88.8 | 306.2 | 231.4 | ||||||||||
|
Impairment, restructuring and reorganization
charges
(1)
|
5.9 | 13.3 | 13.3 | 24.9 | ||||||||||
|
Corporate pension and other postretirement benefit
related expense (income)
(2)
|
3.9 | (11.9) | 8.3 | (3.1) | ||||||||||
|
Acquisition-related charges
(3)
|
1.8 | (0.5) | 3.0 | 3.7 | ||||||||||
|
Acquisition-related gain
(4)
|
(0.3) | — | (0.9) | — | ||||||||||
|
Property losses (recoveries) and related expenses
(5)
|
— | (1.7) | — | (3.8) | ||||||||||
| Noncontrolling interest of above adjustments | — | — | 0.2 | — | ||||||||||
|
Provision for income taxes
(6)
|
(8.4) | (1.6) | (26.3) | (5.0) | ||||||||||
| Adjusted Net Income | $ | 91.0 | $ | 86.4 | $ | 303.8 | $ | 248.1 | ||||||
|
Net income attributable to noncontrolling
interest |
3.5 | 2.5 | 8.6 | 5.7 | ||||||||||
| Provision for income taxes (as reported) | 20.4 | 26.6 | 75.1 | 84.2 | ||||||||||
| Interest expense | 14.8 | 16.3 | 45.0 | 52.3 | ||||||||||
| Interest income | (0.5) | (0.9) | (1.7) | (3.0) | ||||||||||
|
Depreciation and amortization expense
(7)
|
41.0 | 41.0 | 125.7 | 122.4 | ||||||||||
| Less: Noncontrolling interest | — | — | 0.2 | — | ||||||||||
|
Less: Provision for income taxes
(6)
|
(8.4) | (1.6) | (26.3) | (5.0) | ||||||||||
| Adjusted EBITDA | $ | 178.6 | $ | 173.5 | $ | 582.6 | $ | 514.7 | ||||||
| Adjusted EBITDA Margin (% of net sales) | 17.2 | % | 19.4 | % | 18.6 | % | 19.6 | % | ||||||
Diluted earnings and adjusted earnings per share in the table below are based on net income attributable to The Timken Company and adjusted net income, respectively, in the table above.
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||
| 2021 | 2020 | 2021 | 2020 | |||||||||||
| Diluted earnings per share (EPS) | $ | 1.14 | $ | 1.16 | $ | 3.97 | $ | 3.04 | ||||||
| Adjusted EPS | $ | 1.18 | $ | 1.13 | $ | 3.94 | $ | 3.25 | ||||||
| Diluted Shares | 77,023,973 | 76,286,136 | 77,157,614 | 76,131,920 | ||||||||||
Reconciliation of segment EBITDA to segment adjusted EBITDA and segment adjusted EBITDA margin:
| Three Months Ended September 30, 2021 | ||||||||||||||
| Mobile | Process | Unallocated Corporate | Total | |||||||||||
| Net Sales | $ | 487.3 | $ | 550.0 | $ | — | $ | 1,037.3 | ||||||
| EBITDA | 53.2 | 129.7 | (15.3) | 167.6 | ||||||||||
|
Impairment, restructuring and reorganization
charges
(1)
|
4.8 | 0.8 | — | 5.6 | ||||||||||
|
Corporate pension and other postretirement benefit
related expense
(2)
|
— | — | 3.9 | 3.9 | ||||||||||
|
Acquisition-related charges
(3)
|
0.2 | 0.2 | 1.4 | 1.8 | ||||||||||
|
Acquisition-related gain
(4)
|
— | — | (0.3) | (0.3) | ||||||||||
| Adjusted EBITDA | $ | 58.2 | $ | 130.7 | $ | (10.3) | $ | 178.6 | ||||||
| Adjusted EBITDA Margin (% of net sales) | 11.9 | % | 23.8 | % | NM | 17.2 | % | |||||||
40
| Nine Months Ended September 30, 2021 | ||||||||||||||
| Mobile | Process | Unallocated Corporate | Total | |||||||||||
| Net Sales | $ | 1,486.0 | $ | 1,639.6 | $ | — | $ | 3,125.6 | ||||||
| EBITDA | 200.1 | 401.9 | (42.3) | 559.7 | ||||||||||
|
Impairment, restructuring and reorganization
charges
(1)
|
6.3 | 6.2 | — | 12.5 | ||||||||||
|
Corporate pension and other postretirement
benefit related expense
(2)
|
— | — | 8.3 | 8.3 | ||||||||||
|
Acquisition-related charges
(3)
|
0.6 | 0.5 | 1.9 | 3.0 | ||||||||||
|
Acquisition-related gain
(4)
|
— | — | (0.9) | (0.9) | ||||||||||
| Adjusted EBITDA | $ | 207.0 | $ | 408.6 | $ | (33.0) | $ | 582.6 | ||||||
| Adjusted EBITDA Margin (% of net sales) | 13.9 | % | 24.9 | % | NM | 18.6 | % | |||||||
| Three Months Ended September 30, 2020 | ||||||||||||||
| Mobile | Process | Unallocated Corporate | Total | |||||||||||
| Net Sales | $ | 428.6 | $ | 466.0 | $ | — | $ | 894.6 | ||||||
| EBITDA | 64.0 | 109.2 | 1.3 | 174.5 | ||||||||||
|
Impairment, restructuring and reorganization
charges
(1)
|
6.6 | 6.2 | 0.3 | 13.1 | ||||||||||
|
Corporate pension and other postretirement
benefit related income
(2)
|
— | — | (11.9) | (11.9) | ||||||||||
|
Acquisition-related charges
(3)
|
(0.5) | (0.2) | 0.2 | (0.5) | ||||||||||
|
Property losses (recoveries) and related expenses
(5)
|
(1.7) | — | — | (1.7) | ||||||||||
| Adjusted EBITDA | $ | 68.4 | $ | 115.2 | $ | (10.1) | $ | 173.5 | ||||||
| Adjusted EBITDA Margin (% of net sales) | 16.0 | % | 24.7 | % | NM | 19.4 | % | |||||||
| Nine Months Ended September 30, 2020 | ||||||||||||||
| Mobile | Process | Unallocated Corporate | Total | |||||||||||
| Net Sales | $ | 1,237.9 | $ | 1,383.6 | $ | — | $ | 2,621.5 | ||||||
| EBITDA | 177.9 | 343.0 | (25.1) | 495.8 | ||||||||||
|
Impairment, restructuring and reorganization
charges
(1)
|
10.2 | 11.5 | 0.4 | 22.1 | ||||||||||
|
Corporate pension and other postretirement
benefit related income
(2)
|
— | — | (3.1) | (3.1) | ||||||||||
|
Acquisition-related charges
(3)
|
2.1 | 1.0 | 0.6 | 3.7 | ||||||||||
|
Property losses (recoveries) and related expenses
(5)
|
(3.8) | — | — | (3.8) | ||||||||||
| Adjusted EBITDA | $ | 186.4 | $ | 355.5 | $ | (27.2) | $ | 514.7 | ||||||
| Adjusted EBITDA Margin (% of net sales) | 15.1 | % | 25.7 | % | NM | 19.6 | % | |||||||
(1)
Impairment, restructuring and reorganization charges (including items recorded in cost of products sold) relate to: (i) plant closures; (ii) the rationalization of certain plants; and (iii) severance related to cost reduction initiatives. The Company re-assesses its operating footprint and cost structure periodically, and makes adjustments as needed that result in restructuring charges. However, management believes these actions are not representative of the Company’s core operations.
(2)
Corporate pension and other postretirement benefit related expense (income) represents actuarial losses and (gains) that resulted from the remeasurement of plan assets and obligations as a result of changes in assumptions or experience. The Company recognizes actuarial losses and (gains) in connection with the annual remeasurement in the fourth quarter, or if specific events trigger a remeasurement. Refer to
Note 14 - Retirement Benefit Plans
and
Note 15 - Other Postretirement Benefit Plans
for additional discussion.
(3)
Acquisition-related charges represent deal-related expenses associated with completed and certain unsuccessful transactions, as well as any resulting inventory step-up impact.
(4)
The acquisition-related gain represents a bargain purchase gain on the acquisition of the assets of Aurora that closed on November 30, 2020.
(5)
Represents property loss and related expenses during the periods presented (net of insurance recoveries received in 2020) resulting from property loss that occurred during the first quarter of 2019 at one of the Company's warehouses in Knoxville, Tennessee and during the third quarter of 2019 at one of the Company's warehouses in Yantai, China.
41
(6)
Provision for income taxes includes the net tax impact on pre-tax adjustments (listed above), the impact of discrete tax items recorded during the respective periods as well as other adjustments to reflect the use of one overall effective tax rate on adjusted pre-tax income in interim periods.
(7)
Depreciation and amortization shown excludes depreciation recognized in reorganization charges, if any.
Free Cash Flow:
Free cash flow represents net cash provided by operating activities less capital expenditures. Management believes free cash flow is useful to investors because it is a meaningful indicator of cash generated from operating activities available for the execution of its business strategy.
Reconciliation of net cash provided by operating activities to free cash flow:
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||
| 2021 | 2020 | 2021 | 2020 | |||||||||||
| Net cash provided by operating activities | $ | 105.8 | $ | 153.6 | $ | 284.6 | $ | 457.2 | ||||||
| Capital expenditures | (43.1) | (29.2) | (103.6) | (85.7) | ||||||||||
| Free cash flow | $ | 62.7 | $ | 124.4 | $ | 181.0 | $ | 371.5 | ||||||
42
Ratio of Net Debt to Adjusted EBITDA:
The ratio of net debt to adjusted EBITDA for the trailing twelve months represents total debt less cash and cash equivalents divided by adjusted EBITDA for the trailing twelve months. T
he Company presents net debt to adjusted EBITDA because it believes it is more representative of the Company's financial position as it is reflective of the Company's ability to cover its net debt obligations with results from its core operations. Net income for the trailing twelve months ended September 30, 2021 and December 31, 2020 was $370.1 million and $292.4 million, respectively.
Net debt to adjusted EBITDA for the trailing twelve months was 1.6 at September 30, 2021, compared with 1.9 at December 31, 2020.
Reconciliation of Net income to Adjusted EBITDA for the trailing twelve months:
| Twelve Months Ended | ||||||||
|
September 30,
2021 |
December 31,
2020 |
|||||||
| Net income | $ | 370.1 | $ | 292.4 | ||||
| Provision for income taxes | 94.8 | 103.9 | ||||||
| Interest expense | 60.3 | 67.6 | ||||||
| Interest income | (2.4) | (3.7) | ||||||
| Depreciation and amortization | 168.4 | 167.1 | ||||||
| Consolidated EBITDA | 691.2 | 627.3 | ||||||
| Adjustments: | ||||||||
|
Impairment, restructuring and reorganization charges
(1)
|
$ | 16.3 | $ | 25.9 | ||||
|
Corporate pension and other postretirement benefit related expense
(2)
|
29.9 | 18.5 | ||||||
|
Acquisition-related charges
(3)
|
3.0 | 3.7 | ||||||
|
Acquisition-related gain
(4)
|
(12.0) | (11.1) | ||||||
| Gain on sale of real estate | (0.4) | (0.4) | ||||||
|
Property losses (recoveries) and related expenses
(5)
|
(1.7) | (5.5) | ||||||
| Tax indemnification and related items | 0.5 | 0.5 | ||||||
| Total Adjustments | 35.6 | 31.6 | ||||||
| Adjusted EBITDA | $ | 726.8 | $ | 658.9 | ||||
| Net Debt | $ | 1,194.2 | $ | 1,244.3 | ||||
| Ratio of Net Debt to Adjusted EBITDA | 1.6 | 1.9 | ||||||
(1)
Impairment, restructuring and reorganization charges (including items recorded in cost of products sold) relate to: (i) plant closures; (ii) the rationalization of certain plants and (iii) severance related to cost reduction initiatives. The Company re-assesses its operating footprint and cost structure periodically, and makes adjustments as needed that result in restructuring charges. However, management believes these actions are not representative of the Company’s core operations.
(2)
Corporate pension and other postretirement benefit related expense represents actuarial losses and (gains) that resulted from the remeasurement of plan assets and obligations as a result of changes in assumptions or experience. The Company recognizes actuarial losses and (gains) in connection with the annual remeasurement in the fourth quarter, or if specific events trigger a remeasurement.
(3)
Acquisition-related charges represent deal-related expenses associated with completed and certain unsuccessful transactions, as well as any resulting inventory step-up impact.
(4)
The acquisition-related gain represents a bargain purchase gain on the acquisition of the assets of Aurora that closed on November 30, 2020.
(5)
Represents property loss and related expenses during the periods presented (net of insurance recoveries received in 2020) resulting from property loss that occurred during the first quarter of 2019 at one of the Company's warehouses in Knoxville, Tennessee and during the third quarter of 2019 at one of the Company's warehouses in Yantai, China.
43
FORWARD-LOOKING STATEMENTS
Certain statements set forth in this Form 10-Q and in the Company's Annual Report on Form 10-K for the year ended December 31, 2020 that are not historical in nature (including the Company's forecasts, beliefs and expectations) are “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995. In particular, Management's Discussion and Analysis contains numerous forward-looking statements. Forward-looking statements generally will be accompanied by words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “forecast,” “outlook,” “intend,” “may,” “possible,” “potential,” “predict,” “project” or other similar words, phrases or expressions. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this Form 10-Q. The Company cautions readers that actual results may differ materially from those expressed or implied in forward-looking statements made by or on behalf of the Company due to a variety of factors, such as:
•
deterioration in world economic conditions, or in economic conditions in any of the geographic regions in which the Company or its customers or suppliers conduct business, including adverse effects from a global economic slowdown, terrorism, or hostilities. This includes: political risks associated with the potential instability of governments and legal systems in countries in which the Company or its customers or suppliers conduct business, changes in currency valuations and recent world events that have increased the risks posed by international trade disputes, tariffs and sanctions;
•
negative impacts to the Company's business, results of operations, financial position or liquidity, disruption to the Company's supply chains, negative impacts to customer demand or operations, and availability and health of employees, as a result of COVID-19 or other pandemics and associated governmental measures such as restrictions on travel and manufacturing operations;
•
the effects of fluctuations in customer demand on sales, product mix and prices in the industries in which the Company operates. This includes: the ability of the Company to respond to rapid changes in customer demand, disruptions to the Company's supply chain, logistical issues associated with port closures or congestion, delays or increased costs, the effects of customer or supplier bankruptcies or liquidations, the impact of changes in industrial business cycles, the effects of distributor inventory corrections reflecting de-stocking of the supply chain and whether conditions of fair trade continue in the Company's markets;
•
competitive factors, including changes in market penetration, increasing price competition by existing or new foreign and domestic competitors, the introduction of new products or services by existing and new competitors, and new technology that may impact the way the Company’s products are produced, sold or distributed;
•
changes in operating costs. This includes: the effect of changes in the Company’s manufacturing processes; changes in costs associated with varying levels of operations and manufacturing capacity; availability and cost of raw materials and energy; changes in the expected costs associated with product warranty claims; changes resulting from inventory management and cost reduction initiatives; the effects of unplanned plant shutdowns; the effects of government-imposed restrictions meant to address climate change; and changes in the cost of labor and benefits;
•
the success of the Company’s operating plans, announced programs, initiatives and capital investments; the ability to integrate acquired companies and to address material issues not uncovered during the Company's due diligence review; and the ability of acquired companies to achieve satisfactory operating results, including results being accretive to earnings, realization of synergies and expected cash flow generation;
•
the Company’s ability to maintain appropriate relations with unions or works councils that represent Company associates in certain locations in order to avoid disruptions of business and to maintain the continued service of our management and other key employees;
•
unanticipated litigation, claims, investigations or assessments. This includes: claims, investigations or problems related to intellectual property, product liability or warranty, foreign export and trade laws, competition and anti-bribery laws, environmental or health and safety issues, data privacy and taxes;
•
changes in worldwide financial and capital markets, including availability of financing and interest rates on satisfactory terms, which affect the Company’s cost of funds and/or ability to raise capital, as well as customer demand and the ability of customers to obtain financing to purchase the Company’s products or equipment that contain the Company’s products;
•
the Company's ability to satisfy its obligations and comply with covenants under its debt agreements, maintain favorable credit ratings and its ability to renew or refinance borrowings on favorable terms;
44
•
the impact on the Company's pension obligations and assets due to changes in interest rates, investment performance and other tactics designed to reduce risk; and
•
those items identified under Item 1A. "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2020 or this Form 10-Q.
Additional risks relating to the Company's business, the industries in which the Company operates, or the Company's common shares may be described from time to time in the Company's filings with the Securities and Exchange Commission. All of these risk factors are difficult to predict, are subject to material uncertainties that may affect actual results and may be beyond the Company's control.
Readers are cautioned that it is not possible to predict or identify all of the risks, uncertainties and other factors that may affect future results and that the above list should not be considered to be a complete list. Except as required by the federal securities laws, the Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Refer to information appearing under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of this Form 10-Q. Furthermore, a discussion of market risk exposures is included in Part II, Item 7A. Quantitative and Qualitative Disclosure about Market Risk, of the Company’s Annual Report on Form 10-K for the year ended December 31, 2020. There have been no material changes in reported market risk since the inclusion of this discussion in the Company’s Annual Report on Form 10-K referenced above.
ITEM 4. CONTROLS AND PROCEDURES
(a)
Disclosure Controls and Procedures
As of the end of the period covered by this report, the Company carried out an evaluation, under the supervision and with the participation of the Company’s management, including the Company’s principal executive officer and principal financial officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Exchange Act Rule 13a-15(e)). Based upon that evaluation, the principal executive officer and principal financial officer concluded that the Company’s disclosure controls and procedures were effective as of the end of the period covered by this report.
(b)
Changes in Internal Control Over Financial Reporting
During the Company’s fiscal quarter ended September 30, 2021, there have been no changes in the Company’s internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
45
PART II. OTHER INFORMATION
Item 1. Legal Proceedings
The Company is involved in various claims and legal actions arising in the ordinary course of business. U.S. Securities and Exchange Commission ("SEC") regulations require us to disclose certain information about environmental proceedings when a governmental authority is a party to the proceedings if we reasonably believe that such proceedings may result in monetary sanctions above a stated threshold. Pursuant to such regulations, the Company uses a threshold of $1 million or more for purposes of determining whether disclosure of any such proceedings is required as we believe matters under this threshold are not material to the Company. In the opinion of management, the ultimate disposition of these matters will not have a material adverse effect on the Company’s consolidated financial position or results of operations.
Item 1A. Risk Factors
The Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2020, included a detailed discussion of our risk factors. There have been no material changes to the risk factors included in the Company's Annual Report on Form 10-K for the year ended December 31, 2020. Investors should not interpret the disclosure of any risk factor to imply that the risk has not already materialized.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
Issuer Purchases of Common Shares
The following table provides information about purchases by the Company of its common shares during the quarter ended September 30, 2021.
| Period |
Total number
of shares
purchased
(1)
|
Average
price paid
per share
(2)
|
Total number
of shares purchased as part of publicly announced plans or programs |
Maximum
number of
shares that
may yet
be purchased
under the plans
or programs
(3)
|
||||||||||
| 7/1/2021 - 7/31/2021 | 10 | $ | 80.37 | — | 9,950,000 | |||||||||
| 8/1/2021 - 8/31/2021 | 360,059 | 75.94 | 360,000 | 9,590,000 | ||||||||||
| 9/1/2021 - 9/30/2021 | 40,000 | 74.77 | 40,000 | 9,550,000 | ||||||||||
| Total | 400,069 | $ | 75.82 | 400,000 | ||||||||||
(1)
Of the shares purchased in
July and August,
10 and 59
respectively, represent common shares of the Company that were owned and tendered by employees to
exercise stock options and to satisfy withholding obligations in connection with the exercise of stock options or vesting of restricted shares.
(2)
For shares tendered in connection with the vesting of restricted shares, the average price paid per share is an average calculated using the daily high and low of the Company's common shares as quoted on the New York Stock Exchange at the time of vesting. For shares tendered in connection with the exercise of stock options, the price paid is the real-time trading stock price at the time the options are exercised.
(3)
On February 12, 2021, the Company's Board of Directors approved a new share purchase plan, effective March 1, 2021, pursuant to which the Company may purchase up to ten million of its common shares, in the aggregate. This share purchase plan expires on February 28, 2026. Under this plan, the Company may purchase shares from time to time in open market purchases or privately negotiated transactions, and it may make all or part of the purchases pursuant to accelerated share repurchases or Rule 10b5-1 plans. The previous share purchase plan expired on February 28, 2021.
46
Item 6. Exhibits
| Certification of Richard G. Kyle, President and Chief Executive Officer (principal executive officer) of The Timken Company, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |||||
| Certification of Philip D. Fracassa, Executive Vice President and Chief Financial Officer (principal financial officer and principal accounting officer) of The Timken Company, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | |||||
| Certifications of Richard G. Kyle, President and Chief Executive Officer (principal executive officer) and Philip D. Fracassa, Executive Vice President and Chief Financial Officer (principal financial officer and principal accounting officer) of The Timken Company, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |||||
|
Financial statements from the quarterly report on Form 10-Q of The Timken Company for the quarter ended September 30, 2021 filed on November 1, 2021, formatted in Inline XBRL: (i) the Consolidated Statements of Income, (ii) the Consolidated Statements of Comprehensive Income, (iii) the Consolidated Balance Sheets, (iv) the Consolidated Statements of Cash Flows and (v) the Notes to the Consolidated Financial Statements.
|
|||||
| Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | |||||
47
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| THE TIMKEN COMPANY | ||||||||
| Date: November 1, 2021 | By: /s/ Richard G. Kyle | |||||||
|
Richard G. Kyle
President and Chief Executive Officer (Principal Executive Officer) |
||||||||
| Date: November 1, 2021 | By: /s/ Philip D. Fracassa | |||||||
|
Philip D. Fracassa
Executive Vice President and Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) |
||||||||
48
TABLE OF CONTENTS
Part I. Financial InformationprintItem 1. Financial StatementsprintNote 1 - Basis Of PresentationprintNote 2 - Significant Accounting PoliciesprintNote 1 - Significant Accounting Policies"printNote 3 - AcquisitionsprintNote 3 - Acquisitions (continued)printNote 4 - RevenueprintNote 4 - Revenue (continued)printNote 5 - Segment InformationprintNote 6 - Income TaxesprintNote 7 - Earnings Per ShareprintNote 8 - InventoriesprintNote 9 - Goodwill and Other Intangible AssetsprintNote 10 - Financing ArrangementsprintNote 10 - Financing Arrangements (continued)printNote 11 - ContingenciesprintNote 12 - EquityprintNote 12 - Equity (continued)printNote 13 - Impairment and Restructuring ChargesprintNote 13 - Impairment and Restructuring Charges (continued)printNote 14 - Retirement Benefit PlansprintNote 14 - Retirement Benefit Plans (continued)printNote 15 - Other Postretirement Benefit PlansprintNote 16 - Accumulated Other Comprehensive Income (loss)printNote 16 - Accumulated Other Comprehensive Income (loss) (continued)printNote 17 - Fair ValueprintNote 17 - Fair Value (continued)printNote 18 - Derivative Instruments and Hedging ActivitiesprintNote 18 - Derivative Instruments and Hedging Activities (continued)printItem 2. Management's Discussion and Analysis Of Financial Condition and Results Of OperationsprintItem 3. Quantitative and Qualitative Disclosures About Market RiskprintItem 4. Controls and ProceduresprintPart II. Other InformationprintItem 1. Legal ProceedingsprintItem 1A. Risk FactorsprintItem 2. Unregistered Sales Of Equity Securities and Use Of ProceedsprintItem 6. Exhibitsprint